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Population ageing and health care expenditure 
 
National levels of health care spending are rising in many developed countries. Faced 
with increasing pressure on public finances, policy-makers are directing their attention 
towards the potential causes of this rise. Population ageing is perceived to be an im-
portant cause. For example, the Netherlands Bureau for Economic Policy Analysis esti-
mated that population ageing caused 20% of the total rise in real health care expendi-
ture (HCE) per capita in the Netherlands between 1972 and 2010.1 Consequently, if this 
growth rate is extrapolated and other important factors are left aside – such as techno-
logical innovation, health policy restructuring and the Baumol effect1 – population age-
ing will require Dutch citizens to spend 23% more on health care through taxes and 
premiums in 2040 than they did in 2010. 
In contrast, other authors have found that population ageing only has a modest 
or even ignorable impact on health care costs.2-4 They consistently find that technolog-
ical innovations have been the major driver of growth in health care spending on the 
national level in recent decennia, and the demographic factors like population ageing 
play a minor or even insignificant role. Such contrasting results in literature on popula-
tion ageing exist because population ageing itself is a complex dynamic involving many 
facets. Not only does a high degree of uncertainty surround these facets, many forecasts 
do not include all facets. In general, the term population ageing refers to three dynam-
ics: (1) rising life expectancy; (2) a higher share of older people; and (3) increased mor-
tality rates. These three dynamics have different implications for future health care 
spending, each with many different scenarios.  
Rising life expectancy will only result in increased HCE if people will also live 
longer with health related problems. Otherwise, more life years will only postpone an 
increase in HCE. It is also possible that a higher life expectancy will dampen HCE (see 
next paragraph). Concerning the second dynamic, the share of older people is increas-
ing and older people consume a relatively high share of health care. In 2007, Dutch cit-
izens aged 65 years and older made up 15% of the total population, but were responsi-
ble for 37.5% of the total level of health care spending, equalling 27.75 billion of roughly 
                                                          
1 The Baumol effect refers to an economic law, which stipulates that economic growth is logi-
cally accompanied by decreased efficiency in the public sector. The central idea is that increased 
labour productivity boosts economic growth, but that this increase in productivity is most pro-
nounced in the private sector. Efficiency in the public sector then decreases because productiv-
ity lags behind that of the private sector while wages need to increase to prevent income dispar-
ity between these sectors. 
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74 billion euros.5,6 When taking into consideration that the share of seniors is fore-
casted to rise up to 26% in 2040, there is prima facie evidence for a considerable impact 
of population ageing on HCE through this second dynamic (in this case, a rise from 74 
billion to 88 billion from 2007 to 2040, equalling ±424 million euros annually). How-
ever, this simple extrapolation does not take the many counteracting dynamics into ac-
count, such as the ‘red herring’ phenomenon.2  
The red herring phenomenon is related to the third dynamic: increased mortality 
rates. It refers to the notion that a strong rise in HCE by age on the population level 
conceals that there is actually not a strong rise in HCE by age on the individual level. On 
the individual level, in contrast, HCE increase only slightly with age, but rapidly before 
death. What then underlies the association between age and HCE on a population level 
is actually a rising mortality risk in combination with high ‘costs of dying,’ and not a 
presumed direct impact of age on HCE.7 It is important to note here that the costs of 
dying decrease with age.11 Economists therefore conclude that it is important to include 
predictions about age, mortality and the costs of dying in forecasts concerning HCE, ra-
ther than just age8,9 – although some economic researchers do not agree with this 
point.10,11  
 
Aim and outline of this thesis 
To gain a better understanding of how the ageing of a population affects health care 
spending, it is important to investigate the three separate dynamics that underlie the 
association between HCE and population ageing. Therefore, the aim of this thesis is to 
investigate the determinants of mortality, health care expenditure and the costs of dying 
in the older population. The different determinants investigated in this thesis can be 
separated in two categories: (1) determinants that apply to the country as a whole 
(macro-level) – e.g. the status of the national economy; and (2) determinants relevant 
for the individual (micro-level) – e.g. a person’s relationship status. Part I of this thesis 
(chapter 2─4) is dedicated to macro-level determinants, and part II (chapters 5─7) deals 
with the micro-level. 
 
  
                                                          
2 The term ‘red herring’ refers to an illusionary tactic to draw one’s attention away from the real 
problem. In economics, one creates a red herring when extrapolating a dependent variable 
without separately including all the possible determinants of the dependent variable in the 
forecasting model. 
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Overview of the chapters 
Studies have found that rates in unemployment and economic growth affect the mor-
tality rates of a population. It is unclear if and how economic growth is associated with 
mortality at older age. This is investigated in chapter 2. Another important macro-level 
determinant of mortality is seasonality. It is known that mortality rates of older people 
are higher in cold seasons and during heat waves, but it is unknown if seasonal cycles 
exist in medical care expenses and the institutionalization rates of older people. Chap-
ter 3 deals with this issue. Chapter 4 focuses on the national health care system. Spe-
cifically, the idea that the effective use of general practitioners (GPs) can increase the 
cost-effectiveness of the national health care system is investigated. When GPs act as 
gatekeepers utilization of more expensive specialist care is avoided through selective 
referral, improved coordination, and the GPs ability to perform basic treatments at 
lower costs. However, the cost-effectiveness of such a gatekeeping system has not been 
studied properly. 
Part II (the micro-level) starts with a chapter on personalized medicine. The care 
network surrounding frail older people is usually of a bureaucratic and complex nature, 
which comes at the expense of their health as well as the efficiency of regional health 
care supply. In chapter 5 a programme is described that aims to improve the health of 
hospitalized frail older people by improving their network through the individual tai-
loring of care. Not only the structure of the formal care network is important for the 
health of the elderly patient, and the efficiency of health care of older patients: the in-
formal care network is also of crucial importance. The most important part of an older 
person’s care network is the spouse. It is known that married older people live in better 
health and have a lower mortality risk. The effect on marital status on HCE needs fur-
ther exploration. The effect of the loss of the spouse on HCE through time is reported in 
chapter 6. Finally, chapter 7 concerns the costs of dying. The focus lies on four deter-
minants on which current literature is non-existent or controversial: variation in the 
cost of dying, and the role of socio-demographic characteristics, different health ser-
vices, and preceding HCE in the costs of dying. The key findings of this thesis are dis-
cussed in chapter 8, which also concerns the impact of these findings on the debate 
about the impact of population ageing on HCE. 
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Supplementary material  
 
The Dutch health care system 
Health care in the Netherlands can be separated into two main sectors: medical care 
and long-term care. Medical care refers to consultations, medication and treatment 
from general practitioners, medical specialists, dentists, pharmacists, and therapists 
(such as physiotherapists and psychotherapists). Some forms of instrumental aid and 
transportation are also provided through the medical care sector. In the studied time 
period, health care providers bill health care insurers in the form of diagnosis related 
groups. Medical care is legally arranged through the Health Insurance Act (HIA).  
Long-term care in the Netherlands is legally arranged through the Exceptional 
Medical Expenses Act (EMEA). Entitled to care through the EMEA are people who can-
not satisfy their basic care needs independently due to a physical, psychogeriatric or 
psychiatric ailment, or a mental, physical or sensorial handicap. Before someone may 
receive long-term care through the EMEA, the Center for Indication Setting has to eval-
uate the client’s health status and issue an official indication. When an indication is set 
for a client, the actual provision of long-term care is arranged by so-called care offices. 
After an indication is set, the care office appoints a health care provider for a client, or 
distributes a personal budget. The health care insurer who has the highest share of cli-
ents in a region acts as the care office for that region.  
There were basically five separate long-term care services funded through the 
EMEA in the studied time period: (1) personal care (e.g. dressing, undressing, help with 
bathing or showering), (2) nursing care (e.g. wound dressing), (3) counseling (daytime 
activities and help with improving self-reliance, individually tailored or in groups), (4) 
treatment (forms of rehabilitation or therapy) and (5) residence. Indications for extra-
mural care are defined in type and level (hours per week). Since July 1st 2007, intramu-
ral care is indicated in terms of Care Weight Packages (CWPs). CWPs are pre-defined 
bundles of residential care, consisting of housing with different types of long-term care 
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Background: As mortality is more and more concentrated at old age, it becomes critical 
to identify the determinants of old age mortality. It has counter-intuitively been found 
that mortality rates at all ages are higher during short-term increases in economic 
growth. Work-stress is found to be a contributing factor to this association, but cannot 
explain the association for the older, retired population.  
Methods: Historical figures of gross domestic product (Angus Maddison) were com-
pared with mortality rates (Human Mortality Database) of middle aged (40-44 years) 
and older people (70-74 years) in nineteen developed countries for the period 1950 
through 2008. Regressions were performed on the de-trended data, accounting for au-
tocorrelation, and aggregated using random effects models. 
Results: Most countries show pro-cyclical associations between the economy and mor-
tality, especially with regard to male mortality rates. On average, for every 1% increase 
in gross domestic product, mortality increases with 0.36% for 70-74 year old men 
(p<.001) and 0.38% for 40-44 year old men (p<.001). The effect for women is 0.18% 
for 70-74 year olds (p=.012) and 0.15% for 40-44 year olds (p=.118).  
Conclusions: In developed countries, mortality rates increase during upward cycles in 
the economy, and decrease during downward cycles. This effect is similar for the older 
and middle aged population. Traditional explanations as work-stress and traffic acci-
dents cannot explain our findings. Lower levels of social support and informal care by 
the working population during good economic times can play an important role, but 
this remains to be formally investigated.  






Life expectancy in developed countries is continuously on the rise.1 A major part of the 
longevity increase was due to a mortality reduction at younger age, but is now mainly 
attributable to a reduction of old age mortality.2,3 It is therefore important to investigate 
the determinants of old age mortality. Long-term economic growth is an important de-
terminant of lower mortality rates of older people, as wealth creates health.4-6 Since 
many developed countries are currently in a recession, one could expect this has a 
dampening effect on old age survival. However, it has been found that annual increases 
in unemployment, or decreases in gross domestic product (GDP), are associated with 
lower mortality rates at all ages. The association between macroeconomic cycles and 
mortality remains unknown. Since many developed countries are facing a recession, as 
well as a growing share of older people, there is a strong case to study the relation be-
tween macroeconomic cycles and old age mortality. 
An association between mortality and short-term fluctuations in unemployment 
rates or GDP was found to exist in Germany,7 Japan,8 Mexico,9 Spain,10 Sweden11,12 and 
the US.13-17 Two papers analyzed the association in multiple countries, but only used 
age-standardized mortality rates.18,19 The counter-intuitive association between the 
economy and mortality has been explained by increased job-related stress, higher risk 
of traffic accidents, and more unhealthy lifestyles during years of lower unemployment. 
Other explanations include lagged rather than concomitant effects (economic expan-
sions diminish mortality rates, but with a delay)20,21 or spurious correlation due to 
methodological issues.22,23 Currently, the mechanisms underlying the association re-
main largely unknown. Of the aforementioned studies on mortality and short-term fluc-
tuations in unemployment rates or GDP, a few considered old age mortality. Neumayer,7 
Tapia-granados,10 Ruhm,13 and Miller et al.17 report that the association between short-
term fluctuations in unemployment and mortality was also existent and relatively 
strong for older age categories, but further research is needed. Older, retired people 
will hardly be influenced by job-related stress, and they will not change their lifestyles 
as much as their younger working counterparts during different economic tides. All in 
all, older people are overlooked in many epidemiological studies on the association be-
tween the economic environment and mortality, and current explanations for the asso-
ciation do not suffice for older people. This is striking considering that many countries 
stand on the threshold of important demographic and financial changes.  
 
 




The aim of the present study is to explore and analyze the association between macro-
economic cycles and cyclic variation in mortality rates of middle aged and older people. 
There are two main differences between our study and the aforementioned studies. 
First, rather than comparing mortality rates with annual fluctuations in unemployment 
or GDP, we compare cycles lasting several years. Second, we focus on old age mortality 
and compare this with a middle age working group. We also study this in a large group 
of countries, rather than in a single country. Other studies in multiple countries did not 





Data of gross domestic product per capita (GDP) and mortality of 19 developed coun-
tries between 1950 and 2008 were obtained from Angus Maddison’s dataset and the 
Human Mortality Database respectively.24 Maddison’s dataset was used because it com-
prises data over a long period of time. To compare long cycles in the economy with 
changes in the trends of mortality, we considered that a dataset encompassing at least 
50 years of data per country is required. The dataset offers estimated historical figures 
of GDP, defined as Geary-Khamis (G-K) dollars with purchasing power held constant 
with 1990 as the price level year. Geary and Khamis offered a credited alternative to 
price power parity adjusted figures of other economic institutes, such as the World 
Bank. Many studies on the association between the economy and mortality use unem-
ployment as an indicator for a country’s economic status, sometimes with income fig-
ures. We use GDP rather than unemployment for two reasons. First, only a few older 
people have jobs, so they are probably more directly influenced by changes in GDP ra-
ther than employment. Second, unemployment figures do not date back far enough to 
provide a long enough time frame. 
Mortality rates were obtained from the Human Mortality Database for two age 
categories. The age group of 40 through 44 years old was chosen as the younger age 
group, because this group is chronologically in the middle of the working population of 
20 to 60-65 years old. The older age group consists of people of 70 through 74 years 
old, who stand in the middle of the recently retired and the oldest old. The year 1950 is 
used as a starting point, because a dataset could then be collected that is up to date, 
large and does not suffer from the impact of two world wars and a recession in the in-
terbellum. All 34 OECD countries were initially eligible for inclusion, but 14 countries 
were excluded because data concerning gross domestic product or mortality were un-
available for the selected time period.  










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In addition, Hungary was excluded because of methodological issues (see statistical 
analysis) and a turbulent historic background – including repression, revolution, and 
the shift from a plan economy into a capitalist economy. Characteristics of the nineteen 
included countries are shown in table 1.  
 
Statistical analysis 
To capture cyclical variation in the economy and mortality, we transformed real figures 
of gross domestic product and mortality rates into percentual deviations around the 
long-term trend. The long-term trend of GDP is expressed as the log-linear function  
 
log GDP = α + β*Y + ε 
 
where GDP stands for gross domestic product, α for the intercept, β for the regression 
coefficient, Y for year (1950-2008), and ε for the error term. Using this method, the con-
stant growth or decline rate is filtered out to retrieve the cyclic movements around its 
long-term trend and prevent interference from the trend itself. The average fit (R2) of 
all log-linear functions for GDP and mortality in the 19 included countries was 0.89. 
Hungary was excluded, in part because of the low fit of the long-term trends (R2=0.47). 
Figure 1 portrays figures of GDP (a) and mortality (b) as well as their long-term trends 
for the Netherlands from 1950 through 2008. In both panels, the arrow shows an ex-
ample of a deviation. In previous literature, authors comparing GDP and mortality often 
use deviations from the Hodrick-Prescott trend.  
Separate analyses were performed for each country, gender and age group. Per-
centual deviations from the long-term trend are calculated by subtracting the log-linear 
function from the real figures, and expressing this value as a percentage of the log-linear 
function. In each separate analysis, deviations of mortality are regressed on deviations 
of GDP in a linear regression model. Due to their cyclic nature, data in subsequent years 
are likely to be correlated: standard regressions would therefore underestimate uncer-
tainty. Instead, we used Cochrane–Orcutt regression to account for autocorrelation and 
calculated Durbin-Watson test statistics.  
The separate analyses were aggregated over all countries using a meta-analysis 
with a random effects model for continuous variables: the overall coefficients with con-
fidence intervals were estimated from the separate estimated coefficients and standard 
errors for the nineteen countries.25 Data transformations were performed in SPSS 21.0. 
All statistical analyses were performed using Stata/IC 9.2. 
 





Figure 1. Macroeconomic cycles and cylical variation in mortality, the Nether-
lands 1950-2008: Example of the methods. Shown are real figures and long-term 
trends (log-linear functions) of gross domestic product (a) and mortality rates (b). 











According to the Durbin-Watson test statistic,26 70 of the 76 analyses (4 groups in 19 
countries) show signs of autocorrelation. After applying the Cochrane-Orcutt method 
only seven associations still showed signs of autocorrelation. The following results are 
all adjusted for autocorrelation. 
 
Macroeconomic cycles and mortality 
In the long term, an increase in gross domestic product (GDP) is associated with a de-
crease in mortality in all countries. However, the cycles around the trends in GDP and 
mortality show a different association. An example of the association is given in figure 
2. Here, percentual deviations from the trend for GDP and mortality in men aged 40-44 
are shown for the Netherlands from 1950 through 2008. The deviations in GDP and 
mortality show a parallel, or pro-cyclical, movement. This means that mortality rises in 
the Netherlands when its economy is in an upward cycle, or in other words, when the 
economy expands.  
Figure 2. Parallel movement between macroeconomic cycles and cyclical variation in mortality 
in the Netherlands from 1950 through 2008. Cyclical variation in gross domestic product (GDP) 
and mortality are defined as percentual deviations from the long-term trend. 




The forest plots in figure 3 summarize the associations between macroeconomic cycles 
and cyclical variation in mortality for all the analyzed countries. The means, confidence 
intervals, and significance levels of the associations are presented in supplementary ta-
ble 1 (page 29). The coefficients in the forest plots reflect the change in percentual de-
viations from the long-term trend for mortality with every 1% change in deviations of 
the country’s GDP. A positive coefficient thus stands for a pro-cyclical association, 
whereby mortality increases during economic expansion.  
For males aged 70 through 74, mortality rates increase in 17 of the 18 countries 
when the economy expands (analysis for men aged 40-44 in Norway could not be per-
formed, since transformation of autocorrelation properties was not possible). Of these 
pro-cyclical associations seven are significant. On average, mortality in older males 
show an increase of 0.36% (CI 95% 0.22 to 0.50; p<.001) for every one percent the mac-
roeconomic cycle moves upward. For the middle age male group, mortality rates in 16 
countries also show a pro-cyclical movement, of which seven are significant. On aver-
age, mortality trends of males age 40-44 increase with 0.38% (CI 95% 0.19 to 0.56; 
p<.001) for every percent the economy expands. 
For females aged 70 through 74 (figure 3), mortality rates increase in 16 coun-
tries when the economy expands. Seven of these pro-cyclical associations are signifi-
cant. The remaining three anti-cyclical associations are all significant (Canada, Ireland 
and Sweden). On average, mortality for this age group increases with 0.18% (95% CI 
0.04 to 0.32; p=.012) when the macroeconomic cycle moves upward with 1%. Mortality 
rates of females age 40 through 44 show a pro-cyclical association in 12 countries, of 
which six are significant. Of the seven anti-cyclical associations, two are significant (Fin-
land and Japan). On average, mortality trends of females age 40-44 increase with 0.15% 
(CI 95% -0.04 to 0.34; p=.118) for every percent the macroeconomic cycle goes up-
wards. 
It is plausible that a pro-cyclical movement between the economy and mortality 
exists. Gerdtham and Ruhm have found that a 1% decrease in unemployment is associ-
ated with a 0.4% increase in cardiovascular disease, 1.1% in influenza/pneumonia, 
1.8% in liver disease, 2.1% in motor vehicle deaths, and 0.8% in other accidents.18 
Lower unemployment rates during downward cycles in gross domestic product can in-
duce these job-related stress factors. However, direct job-related factors do not explain 
our finding that older people react at least similarly to changes in the economy as mid-
dle age people. It is known that air pollution increases during economic expansions,27 
but evidence for a relation with mortality in older people is lacking. 
 





Figure 3. Associations between macroeconomic cycles and cyclical variation in mortality. Shown 
are associations of a 1% rise in the macroeconomic cycle with a change in the cyclical variation 
of mortality. A positive coefficient shows that mortality rises during economic expansion, and 
lowers during economic downturns. Estimates are coefficients from a linear regression model 
with corresponding 95% confidence intervals. Open symbols represent the weighted average and 
95% confidence interval as derived from a random effects model. The association for men age 
40-44 in Norway is missing, because the transformation of autocorrelation properties was not 
possible. 




Furthermore, air pollution doesn’t explain why men suffer more during good economic 
times than women. It could be that other factors are at play at higher ages. For example, 
changes in social support can have a considerable impact on old age mortality.28-31 
When employment rates and the amounts of workload increase for the working popu-
lation, it is plausible that there is less time for informal care-giving by younger relatives 
and friends for the chronically ill or oldest old. Also, the non-working older partner can 
be overburdened with informal care when the working children have less spare time, 
leading to higher mortality in the older care-giver group.32  
Another possible explanation of the first kind is of a psychosocial nature, known 
as the inhibition effect.22 Studies show that persons who remain employed during times 
of higher unemployment reduce their alcohol consumption, and exhibit less antisocial 
behavior.33,34 Also, the number of road accidents and other traumas decreases with 
higher unemployment, although suicide and homicide rates increase.35,36 Ruhm found 
that during times of lower unemployment smoking and obesity figures increase, diets 
become more unhealthy, and physical exercise decreases.14 It could be that older people 
show the same kind of inhibition effect during downward cycles in the economy. The 
effect might even be stronger for pensioners, because they do not have the effect of in-
creased risk of mortality by unemployment to counterbalance the inhibition effect. On 
the other hand, older people are less inclined to show this kind of behavior on the basis 
of changes in gross domestic product, since they are less dependent on the economy 
than employed or job-seeking individuals. Also, unhealthy lifestyles usually do not re-
sult in increased mortality risk immediately, but some years later. 
Secondly, one could also argue for reversed causality and that changes in mor-
tality rates influence economic variables. Macroeconomic cycles are partly dependent 
on shifts in the demographic composition of a country, such as immigration and labor 
force supply. Taking this point of view, one could argue that old age mortality influences 
the economy. If mortality rates of the non-working population increase relative to those 
of the working population, average figures of labor productivity per capita will increase, 
raising per capita figures of gross domestic product.  
Thirdly, economic expansions may decrease mortality with a delay. What seems 
as concomitant variation on first sight, could be a lagged reversed causal relation in re-
ality. Some authors propose this delayed effect is the true dynamic behind the found 
effect of short-term fluctuations in the economy and mortality.20,21 However, graphs 
comparing deviations in gross domestic product and mortality for the nineteen investi-
gated countries show that cycles move in a concomitant fashion, and no lag effects can 
be detected.  




Finally, there could be a spurious association between economic and mortality fig-
ures.22-23 In this case, methodological issues in time-series analyses, or the existence of 
a third variable, are at play. Concerning methodological issues, we tried to avoid an im-
portant caveat by adjusting for autocorrelation. Concerning a third variable, many de-
terminants or even confounders could cause changes in economic and mortality figures, 
such as health policies, air pollution, or informal care. To acquire enough data to analyze 
macroeconomic cycles, a dataset comprising many years was needed. More specific 
data on potential explanatory variables were not available for the selected time period. 
Furthermore, data about underlying causes of mortality rates are available through the 
OECD, but these data are only available for age-standardized mortality rates, and not 
age-specific mortality rates.  
This implies that further research with the inclusions of such omitted variables 
is needed to unravel the seemingly pro-cyclical association between the economy and 
mortality in developed countries. Especially panel studies could greatly contribute to 
our understanding of the dynamics behind the association. This applies especially for 
explaining changes in mortality trends of older people, where current explanations do 
not suffice. Another limitation of our broad dataset is that the many differences be-
tween the here included countries could not be analyzed. We included all countries for 
which figures of gross domestic product and mortality were known from 1950 on-
wards, without paying attention to, for example, the differences in demographic com-
position or culture. The statistically significant reversed relationship we found for 
women in some countries suggest that there is heterogeneity among the countries. 
A strong aspect of this study is that we are the first to compare long cycles in 
gross domestic product and cyclical variation in mortality. Earlier studies on the asso-
ciation between the economic environment and mortality have focused on short-term 
fluctuations in unemployment or gross domestic product. Furthermore, our analysis in-
cludes a very comprehensive dataset with economic and mortality figures in over 50 
years for nineteen developed countries. Earlier studies analyzing multiple countries use 
age-standardized mortality rates only.  
The counter-intuitive association between macroeconomic cycles and cyclical 
variation in mortality needs further explanation. So far, the most plausible explanations 
have been labor-related, but these cannot explain the similar associations we found 
among older people. Higher levels of air pollution and lower levels of informal care and 
social support during good economic times could be major contributors to the associa-
tion, but the evidence on the existence of such dynamics is scant. In times of economic 
turmoil and population ageing, further exploration of the effects the economic environ-
ment can have on the well-being of older people is of great importance. 
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Background: The mortality rates of older people changes with the seasons. However, 
it has not been properly investigated whether the seasons affect medical care expendi-
ture (MCE) and institutionalization. Seasonal variation in MCE is plausible, as MCE rises 
exponentially before death. It is therefore important to investigate the impact of the 
seasons on MCE, either separate from mortality or not.  
Methods: Data on mortality, MCE and institutionalization from people aged 65 and 
older in a region in the Netherlands from July 2007 through 2010 were retrieved from 
a regional health care insurer and were linked with data from the Netherlands Institute 
for Social Research, and Statistics Netherlands (n=61,495). The Seasonal and Trend de-
composition using Loess (STL) method was used to divide mortality rates, MCE, and 
institutionalization rates into a long-term trend, seasonal variation, and remaining var-
iation. For every season we calculated the 95% confidence interval compared to the 
long-term trend using Welch’s t-test.  
Results: The mortality rates of older people differ significantly between the seasons, 
and are 21% higher in the winter compared to the summer. MCE rises with 13% from 
the summer to the winter; this seasonal difference is higher for the non-deceased than 
for the deceased group (14% vs. 6%). Seasonal variation in mortality is more pro-
nounced in men and people in residential care. Seasonal variation in MCE is more pro-
nounced in women. Institutionalization rates are significantly higher in the winter, but 
the other seasons show no significant impact. 
Conclusions: Seasonal changes affect mortality and the level of MCE of older people; 
institutionalization rates peak in the winter. Seasonal variation in MCE exists inde-
pendently from patterns in mortality. Seasonal variation in mortality is similar for both 
institutionalized and community-dwelling elderly. Policy-makers, epidemiologists and 
health economists are urged to acknowledge and include the impact of the seasons in 











Developed countries are faced with ageing populations and increasing health care ex-
penses. Investigating the determinants of health care expenditure in the older popula-
tion is therefore of high importance. Many epidemiological studies show that there is 
seasonal variation in mortality,1-16 but whether medical care expenditure (MCE) also 
shows seasonal variation has not been formally investigated. Since individual levels of 
MCE rise steeply prior to death,17-22 it seems only logical that – as a direct result of sea-
sonal variation in mortality – there is seasonal variation in MCE. However, the level of 
MCE may also change with the seasons due to changes in non-fatal forms of morbidity. 
It is therefore tempting to study seasonal differences in older people’s health also by 
focusing on changes in health care utilization and expenditure separately for individu-
als who died and those who survived.  
It has been found that mortality rates in the older population rise during winter 
time in Europe,8-10,16 the US,6 and low and middle income countries,5,12 and New-Zea-
land.4 Summers are also associated with higher mortality rates.2,3,6,11 A very recent 
multi-country investigation shows that mortality rates gradually increase with colder 
temperatures, but also show a sudden increase when excessive heat occurs.7 Many dif-
ferent factors are thought to underlie the association between ambient temperature 
and morbidity and mortality, such as changes in the risk cardiovascular events,23,24 sus-
ceptibility to infectious diseases,14,25,26 and the risk of incurring a hip fracture.27 The oc-
currence of more strokes and hip fractures during cold seasons implies that the demand 
for institutional care is higher during these seasons. Some studies find that the effect of 
seasonal variation is more prominent in women than men.4,9,16 Socioeconomic differ-
ences did not influence the associations.8,15 
Here, we study the effect of the seasons on MCE and institutionalization (viz., ad-
mittance to a care or nursing home). We aim to answer two research questions: (1) is 
there seasonal variation in mortality rates, medical care expenditure (MCE), and insti-
tutionalization rates (admission rates to care and nursing homes) in Dutch people aged 
65 years or older?; and (2) does seasonal variation in mortality rates, MCE and/or in-
stitutionalization rates differ between subgroups, based on gender, age, vital status 
(close to death or not), and residential status (institutionalized vs. community-dwell-
ing)? We use the ‘STL decomposition method’ to detect a possible seasonal variation in 
the different measures. This method divides the data into a long-term trend, seasonal 
variation around the long-term trend, and ‘remaining’ variation. For the second re-
search question we divide the study population into different subgroups.  
 






The Dutch health care system 
Health care in the Netherlands can be separated into two main sectors: medical care 
and long-term care. Medical care refers to consultations, medication and treatment 
from general practitioners, medical specialists, dentists, pharmacists, and therapists 
(such as physiotherapists and psychotherapists). Some forms of instrumental aid and 
transportation are also provided through the medical care sector. In the studied time 
period, health care providers bill health care insurers in the form of diagnosis related 
groups. Medical care is legally arranged through the Health Insurance Act (HIA).  
Long-term care in the Netherlands is legally arranged through the Exceptional 
Medical Expenses Act (EMEA). Entitled to care through the EMEA are people who can-
not provide in their basic care needs independently due to a physical, psychogeriatric 
or psychiatric ailment, or a mental, physical or sensorial handicap. Before someone may 
receive long-term care through the EMEA, the Center for Indication Setting has to eval-
uate the client’s health status and issue an official indication. When an indication is set 
for a client, the actual provision of long-term care is arranged by so-called care offices. 
After an indication is set, the care office appoints a health care provider for a client, or 
distributes a personal budget. The health care insurer who has the highest share of cli-
ents in a region acts as the care office for that region.  
Indications for residential care are defined in type and level (hours per week). 
Since July 1st 2007, residential care is indicated in terms of Care Weight Packages 
(CWPs). CWPs are pre-defined bundles of care, consisting of different types of long-
term care on different levels, complemented with residence. From July 2007 through 
December 2010, residential care was categorized into ten CWPs: the first four relate to 
different types of residential care in care homes, the second four to nursing homes, the 
9th to rehabilitation, and the 10th to palliative care. 
 
Ethics statement 
After consulting the internal review board (IRB) of the regional health insurer, data on 
health care expenditure were retrieved from a health insurer. A formal waiver of IRB 
approval was received from Statistics Netherlands (Centraal Bureau van de Statistiek) 
for data collection. After consulting the IRB of Statistics Netherlands, a single transfer 
of data from the health insurer to Statistics Netherlands was undertaken over a secure 
line. A formal waiver was received by the IRB of Statistics Netherlands. After the data 
transfer, the Statistics Netherlands first removed any personal data. The leading author 
Chapter 3 | Seasonal variation 
35 
 
could then only access the de-identified data in a secured room of Statistics Nether-
lands. The authors had no access to identifying information. Any output destined for 
publication was first scrutinized by the IRB of Statistics Netherlands, so no output could 
be traced back to individuals. No data are publicly available. Data collection and analysis 
was in full accordance with privacy legislation and protocol. 
 
Data 
With the aim to perform multiple studies on the association between the life situation 
of older people and their health care expenses, the Leiden Health care Costs in Old Age 
(LHCOA) study was started in 2011. For this study, data on health care expenses of 
61,495 people aged 65 and older in a period of 42 months were retrieved from a re-
gional Dutch health insurance company and matched with data on socio-economic char-
acteristics from Statistics Netherlands. Data were collected using the following steps: 
1. After consulting the IRB (legal department) of the regional health insurance com-
pany, data on MCE were retrieved from the management information system of the 
health insurance company. Data were collected for the period July 2007 through 
2010 for all persons who lived in the regions where the health care insurer acted 
as the long-term care office, and who reached the age of 65 before 2011. Addresses 
were linked with data on socio-economic status by postal code, provided by the 
Netherlands Institute for Social Research 
2. In accordance with the IRB of the health insurance company, data on long-term care 
utilization were collected from the EMEA Care Registration system (ECR), an infor-
mation system which offers an oversight of all the coded messages that are sent 
between organizations active within the confounds of the EMEA. ECR messages 
designating the start and end of long-term care provision were used to determine 
whether a client was institutionalized. Institutionalization rate was defined as the 
admission rate to care and nursing homes. 
3. After consulting the IRB of Statistics Netherlands a single transfer of data from the 
health insurer to Statistics Netherlands was done over a secure line. CBS staff 
merged the data using citizen service numbers and dismissed any personal data 
afterwards. The authors could then only access the de-identified data in a secured 
room of Statistics Netherlands. The authors had no access to identifying infor-
mation. Any output destined for publication was first scrutinized by the IRB of Sta-
tistics Netherlands, so no output could be traced back to individuals. Data collection 
and analysis was in full accordance with privacy legislation and protocol. Socio-de-
mographic variables collected at Statistics Netherlands were: age, gender, marital 
status, and time of death. 




The total study population of the LHCOA study (n=61,495) was used to investigate the 
association between the seasons and mortality, medical care expenditure (MCE) and 
institutionalization rate. If an association between seasonal change and mortality as 
well as MCE is found, it will be unclear whether the association with MCE is caused by 
mortality in combination with the high costs of dying, or whether there is a direct asso-
ciation between seasonal changes and MCE. Therefore, the total study population was 
divided into two groups: subjects who died before 2012 (n=9,202), and those that sur-
vived until 2012 (n=52,293). If an association between seasonal changes and MCE ex-
ists in the survivor group, there is evidence for a direct association, separate from mor-
tality rates and the costs of dying. 
Besides splitting up the study population into a deceased and non-deceased 
group, we also separated subgroups on the basis of age, gender, and residential status. 
We divided the population in community-dwellers and institutionalized subjects to fur-
ther investigate the link between mortality and outside temperature. Institutionalized 
subjects were admitted in a care home or nursing home and were therefore predomi-
nantly or even exclusively exposed to a constant inside temperature. If there is also sea-
sonal variation in mortality for the institutionalized, it is plausible that seasonal varia-
tion is caused by other factors than temperature alone. 
 
Statistical analysis 
Seasons represent three-monthly periods. In the Netherlands, the winter season offi-
cially starts on December 21st and ends on March 20th. Therefore, winter data were de-
fined as January, February and March. Spring, summer and autumn were defined using 
the subsequent three monthly periods.  
The Seasonal and Trend decomposition using Loess (STL) method was used to 
analyse seasonal variation in mortality risk, MCE, and institutionalization rate. The STL 
method decomposes longitudinal data into a long-term trend, seasonal variation, and 
remaining variation that does not stem from the long-term trend or from seasonal var-
iation.28 The long-term trend in the STL method reflects an array of possible external 
factors that gradually change over time, such as higher average ages, an increased risk 
of widowhood, changes in health care policy, and inflation. Our aim is to find whether 
seasonal changes are a significant component in the actual data. For every season we 
calculated the 95% confidence interval compared to the long-term trend using Welch’s 









Table 1 shows the characteristics of the study population. The study population in-
cludes 61,495 subjects aged 65 years and older, with an average follow-up of 35.7 
months. Socio-demographic characteristics are shown for the first month of follow-up. 
Also shown is the number of deaths and institutionalizations during follow-up.  
 
Table 1. Characteristics of the study population.a 
 n (%) 
   
All subjects 61,495  
   
Gender   
Men 24,904 (41) 
Women 36,591 (59) 
   
Age   
65-79 49,438 (80) 
80+ 12,057 (20) 
   
Marital status   
Married 35,082 (57) 
Not married 26,413 (43) 
   
Residential status   
Community-dwelling 61,130 (99) 
Institutionalized 365 (1) 
   
During follow-upb   
Deceased 7,040 (11) 
Institutionalized 7,223 (12) 
   
a Data on these characteristics refer to the first month of follow-up. 
b Average individual follow-up is 35.7 months. 
 
Figure 1 visualizes the number of deaths, the level of medical care expenditure (MCE), 
and the number of institutionalizations of the study population, as well as the long-term 
trends and seasonal cycles around the long-term trends of these variables. The long-
term trend is portrayed with a dotted line, and the seasonal cycles around the long-term 
trend are shown with a solid line. There is a strong long-term trend in institutionaliza-
tion rate (panel C) between autumn 2007 and autumn 2011. The number of institution-
alizations per 10,000 persons for every season rises from 46 in the summer of 2007 to 
75 in the winter of 2009. Hereafter, the number slowly decreases towards 62 institu-
tionalizations per 10,000 persons in the autumn of 2010. 




   
 
 
Figure 1. The number of deaths (panel A), level of medical care expenditure (B) 
and number of institutionalizations (C) in a cohort of Dutch older people. The raw 
data are decomposed into a long-term trend (dotted line), and the seasonal varia-
tion, or ‘cycle’, around the long-term trend (solid line). Results are from the Sea-
sonal and Trend decomposition using Loess (STL) method.  
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Figure 2 shows the seasonal variation for mortality rates (panel A), MCE (panel B), and 
institutionalization rates (panel C). The figure expresses the absolute difference from 
the long-term average. The average of all years and seasons is set at zero with the cor-
responding confidence interval as a coloured band. When the point estimate of the sea-
sonal component is outside this confidence interval, it is significantly different from the 
long-term trend. Visible from figure 2 is that all seasonal means differ significantly from 
the long-term trend for mortality and MCE. Institutionalization rates only differ signifi-
cantly from the long-term average during the winter period. 
The average number of deaths (fig 2, panel A) in every season (all three months) 
was 96 per 10,000 persons from July 2007 through 2010 according to the long-term 
trend. On average, there are 9 more deaths per 10,000 population in all three months 
of the winter period (+9%). Similarly, per 10,000 population there are 4 less deaths in 
the spring (–4%), 9 less in the summer (–9%), and 4 more in the autumn (+4%). There-
fore, the average number of deaths per 10,000 population was 87 in the summer and 
105 in the winter. Relatively, the number of deaths in older people is thus 21% higher 
in the winter than in the summer. 
Panel B of figure 2 shows that MCE is also higher in the autumn and winter than 
in the spring and summer. Average MCE per person was €1,231 per season (all three 
months) in the studied time period (based on the long-term trend). Expenditure per 
person was €79 above this average in the winter (+6%), €24 lower in the spring (–2%), 
€76 lower in the summer (–6%), and €23 higher in the autumn (+2%). Consequently, 
seasonal MCE rises with 13% from the summer to the winter (€1,155 vs. €1,310 per 
person). 
The average number of institutionalizations was 65 per 10,000 persons in the 
study period. Only the institutionalization rate in the winter differs significantly from 
the long-term trend, when, on average, 6 more older people are institutionalized per 
10,000 population. Consequently, there is a rise of 9% in institutionalizations in the 
winter compared the long-term average, and, since the institutionalization rate in the 
summer equals the long-term average, it is also 9% higher when comparing the winter 
to the summer (71 vs. 65 per 10,000 persons). The autumn is characterized by the 
lowest number of institutionalizations. 
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In table 2, the specific data are shown for the mortality rates, MCE, and institutionaliza-
tion rates for the total study population (described above), as well as for subgroups 
based on gender, age, residential status and vital status. Visible in table 2 is that for both 
the deceased and non-deceased subgroup, MCE is higher in the autumn and winter and 
lower in the spring and summer. Average MCE was €1,022 per season for individuals 
surviving, and expenditure was €62 above this average in the winter (+6%), €14 lower 
in the spring (–1%), €69 lower in the summer (–7%), and €20 higher in the autumn 
(+2%). Consequently, MCE for the non-deceased group is 14% higher in the winter than 
in the summer (€1,084 vs. €953). In contrast to all the other subgroups, the lowest level 
of MCE in the deceased group is not reached in the summer, but in the spring. Seasonal 
variation is less pronounced in the deceased group: MCE is 6% lower in the summer 
than in the winter for individuals in their last year before death (€4,385 vs. €4,137), 
and 7% lower in the spring (€4,385 vs. €4,102). 
There is greater seasonal variation in the mortality of men than that of women: 
the male mortality rate is 26% higher in the winter than in the summer, and this differ-
ence is 16% for women. In contrast, seasonal changes in MCE are more prevalent for 
women than for men: MCE is 16% higher in the winter than in the summer for women, 
and this difference is 10% for men. There is not much difference between the two age 
groups concerning seasonal variation in mortality rates, MCE and institutionalization 
rates. However, seasonal variations are slightly more concentrated in a winter peak for 
the older patients, and more dispersed throughout the seasons for younger patients. 
There is seasonal variation in mortality rates for both community-dwelling and 
institutionalized subjects. For community-dwellers mortality rates differ significantly 
from the long-term trend in all the seasons. The average number of deaths per 10,000 
persons was 67 in the summer and 81 in the winter, meaning the number of deaths are 
21% higher in the winter compared to the summer. With 27%, this difference between 
the winter and summer is higher for those who were institutionalized. For them, mor-
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Institutionalization rates are consistently lowest in the autumn and highest in the win-
ter, regardless of which subgroup is considered. The size of the relative differences be-
tween the autumn and the winter are also similar across subgroups: the lowest differ-
ence is 13%, found in males and those aged 80 years and older, while the highest differ-




We find that older people die more in the winter and autumn than in the spring and 
summer. Furthermore, their average level of MCE is considerably higher in the winter 
than in the spring and summer, and their risk of institutionalization peaks in the winter. 
Seasonal variation is stronger for men than women, but rather similar between age 
groups, deceased and non-deceased subjects, and institutionalized and community-
dwelling elderly. 
 
Interpretation of results 
Previous studies already showed that mortality in the older population is associated 
with the seasons,1-16 but seasonal variation in MCE is a novel finding. The changes in 
mortality, MCE and institutionalization suggest that older people’s health is affected by 
the seasons. It has been found that health is affected by harsh climate conditions, such 
as cold temperatures,1,2,4,7-10,12,13,15,16 and heat waves.2,3,6,7,9,11-13 In contrast to some of 
these studies, we did not find increased mortality rates during the summer. Higher mor-
tality rates in the summer are related to extremely hot temperatures, mainly during 
heat waves. Extreme hot temperatures are not common in the Netherlands, and, when 
they occur, usually last only several days. 
Different biological pathways could underlie the influence of ambient tempera-
ture on older peoples’ health. For example, it has been found that colder temperatures 
are associated with increased blood pressure,29,30 higher blood-clotting activity,31 and 
decreased lung function in COPD patients.32 In contrast, very warm temperatures can 
also cause physical problems. For example, the thermoregulatory function and heart 
rate variability of older people decrease during extremely warm days.33,34 We could not 
measure whether temperature had a strong influence on mortality, MCE and institu-
tionalization as the time frame of our study is too short for this purpose. Also, the data 
points in our data represent months and quarter years, not days, making the data too 
crude to investigate this properly. The finding that the mortality rates of institutional-
ized elderly changes with the seasons suggests that outside temperature may not even 




play a major role in the seasonal variations found in this study, as the institutionalized 
elderly are subjected to relatively constant inside temperatures. 
Besides ambient temperature, there are many different season-dependent fac-
tors that potentially affect population health. First, it is possible that flu underlies sea-
sonal variation in mortality and MCE, as prevalence rates of flu are higher in the winter, 
and institutionalized people are also – or even more – susceptible to flu compared to 
those in the community setting.35 Second, snow and ice may increase the risk of falls 
and resulting fractures, especially in older people in the community setting.26 Third, 
studies have shown that sunlight has a positive effect on health, such as pain after spinal 
surgery,36 and length of stay and survival after myocardial infarction.37 Fourth, the level 
of air pollution shows an association with seasonal changes, and air pollution has an 
important impact on health outcomes, such as mortality,38 stroke,39 diabetes,40 mental 
health,41,42 and even atherosclerosis.43 Fifth, there is evidence that atmospheric pres-
sure and humidity also affect population health.44,45 Sixth, and finally, it is possible that 
the demand and supply of outpatient care is lower during the summer due to the sum-
mer holidays of clinicians and patients, also leading to lower expenditure levels in this 
season. However, if this would be a major cause of the found seasonal variation in MCE, 
it would be more plausible that MCE is highest in the autumn, and not in the winter, 
because outpatient care would peak after the summer holidays. 
A higher prevalence of flu in the winter, as well as reduced hours of sunlight, may 
explain why older people in residential care also show seasonal variation in their mor-
tality rates. Our analysis shows that men suffer more from seasonal changes than 
women, which stands in contrast to other findings.3,8,15 It is unclear why our results dif-
fer from these previous findings, but it is possible that our study population shows dis-
crepancies with those used in previous studies. 
There are different explanations for the winter peak in institutionalizations. 
First, it is possible that climate conditions drive up the demand for long-term care. In 
this case, an exacerbation of chronic illnesses in the winter could stimulate elderly pa-
tients or their family to choose for more intensive long-term care. Second, it is possible 
that higher mortality rates in the winter drive up the supply of long-term care. In other 
words, a higher number of deaths results in a higher number of vacancies, and, conse-
quently, a higher rate of institutionalizations if care and nursing homes are functioning 
at full capacity. Third, although small changes in long-term care policy took place from 
July 2007 through 2010 – some specific types of home care were abolished – it is im-
plausible that these changes caused a peak in institutionalizations in the beginning of 
each year. 
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Strengths and weaknesses 
The existence of seasonal variation in MCE, both close to death as well as independent 
from impending death, and institutionalization is a novel finding. For the purpose of our 
analysis, we were able to analyse data on a large study population, which could be sep-
arated into several subpopulations, and we used an advanced statistical method to dis-
entangle seasonal variation from a long-term trend and other variation. However, the 
time period over which we could perform our analysis was rather short (three and a 
half years). Because, in addition, the data pertained to monthly or quarterly averages, 
we could not assess the proportional impact of flu, snow and ice, air pollution, sunlight, 
ambient temperatures, or other climate conditions on mortality, MCE and institutional-
ization. Another issue pertains to the representativeness of the study population. The 
study population consists of clients from one health insurer within specific regions of 
the Netherlands. Although the study population is quite comparable to the Dutch pop-
ulation aged 65 and older in terms of gender and marital status, the number of people 
aged 80 and older in the study population was relatively low (20% vs. 26.5%).46 We 
could not ascertain how representative our study population was in terms of other 
characteristics.  
 
Implications and future research 
We performed this study for three reasons: (1) to make policy-makers aware of the im-
pact the seasons can have on the health of older people (if any), as well as the collective 
health care budget; (2) to show epidemiologists and health economists if and how much 
the seasons affect MCE and institutionalization rates; and (3) to find out if specific pa-
tients groups are more at risk during certain seasons – in this case policy-makers and 
clinicians will know which patient groups will most likely benefit from targeted inter-
ventions.  
If the findings from our analysis of the older population in this region of the Neth-
erlands are translated to the entire older Dutch population in 2012 – with a size of ±2.7 
million – they would imply that there were 6,880 more deaths amongst older people in 
the Netherlands in the autumn and winter than in the spring and summer [46]. In addi-
tion, MCE of older people were 630 million Euros higher in the cold than the warm sea-
sons in 2012. For epidemiologists and health economists, it is imperative to 
acknowledge the possible existence of seasonal variation in their data, and include var-
iables representing seasonal variation when performing longitudinal or time series 
analyses. Policy-makers and health care insurers should be aware of the seasonal dif-
ferences in MCE and institutionalization to be able to effectively allocate resources in 
the budgets under their control. 




Furthermore, seasonal variation in mortality rates and medical care expenditure could 
warrant policy changes that could benefit older people and/or decrease the expendi-
ture levels. The finding that institutionalized elderly have a more pronounced seasonal 
variation in mortality, show that these people may benefit from programmes targeting 
health care workers’ vaccination or hygiene, improving sunlight exposure or vitamin D 
status, or promoting better climate control in residential care facilities. To prevent in-
creased levels of MCE or deaths of community-dwellers in the colder seasons, it is of 
primary importance that we understand which climate conditions impact their health, 
and through which biological pathways.  
Further investigations into seasonal changes in health, MCE and mortality should 
preferably use daily data over a long period in time, and include many different varia-
bles, such as ambient temperature, flu prevalence, sunlight hours, air pollution, atmos-
pheric pressure, and humidity. Furthermore, including data on the types of illness or 
causes of death could disclose which biological pathways are mainly associated with 
seasonal changes in health and expenditure.  
 
Conclusions 
Seasonal changes affect the mortality risk and level of medical care expenditure of older 
people; both outcomes are highest in the winter and lowest in the summer. Institution-
alization rates peak in the winter. Seasonal variation is stronger for men than women, 
but similar between age groups. Changes in outside temperature cannot solely explain 
the seasonal variation in mortality because seasonal variation in mortality is similar for 
institutionalized and community-dwelling elderly. Also, seasonal variation in mortality 
cannot solely explain the variation in medical care expenditure, because the seasonal 
variation in medical care expenditure is present in the deceased and non-deceased pop-
ulation. Policy-makers, epidemiologists and health economists are urged to 
acknowledge and include the impact of the seasons in future policy and research. In a 
time where many countries are faced with population ageing, it is imperative that we 
gain insight into the causes of seasonal-dependent health deterioration as well as the 
best clinical means and policy measures to improve the health of older people.  
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Background: An effective primary care system holds potential to curb health care ex-
penditure (HCE), as general practitioners (GPs) provide services that prevent utiliza-
tion of other, often more costly health care services. However, there is insufficient evi-
dence to support this claim. We aim to investigate whether HCE of older people decline 
when they make more use of GP services. 
Methods: Data on medical care expenses and long-term care utilization from clients 
aged 65 and older were retrieved from a regional health care insurer and linked to data 
on long-term care fees from the Health Insurance Board, socio-economic status from 
the Netherlands Institute for Social Research, and other socio-demographic character-
istics from Statistics Netherlands (n=16,433). The association between GP expenditure 
(first 18 months of follow-up) and expenses for other health services later in time (from 
19th month onward) was analysed with generalized linear models and two-part models 
with standardization for mortality, baseline expenses for other health care services, so-
cio-demographic characteristics and time variables. 
Results: For every €10/month of GP expenditure, the expenses for other health care 
services later in time increase with €74/month (p<.001). Specifically, expenses in-
crease with €27/month for hospital care (p<.001), €17/month for medical care ex-
penditure other than GP and hospital care (mainly medication, physio- and psychother-
apy, and instrumental aids), and €33/month for long-term care. 
Conclusions: We found a positive association between GP expenditure and expenses 
for other health care services later in time in a cohort of Dutch older health insurance 
clients. The positive association can be explained by three dynamics: (1) expenses for 
GPs are automatically associated with expenses for other health care services because 
patients often receive or even require a referral from the GP before receiving specialist 
health care; (2) GPs could increase the overall level of HCE by improper diagnoses or 
unnecessary referrals; (3) our statistical methods did not adequately account for the 
likelihood that patients who have more health problems visit GPs and other health care 
providers more frequently. 
  






A strong primary care system is proposed as a policy-instrument for the many countries 
facing important challenges to their health care system, such as a higher share of older 
people, increasing life expectancy, rising levels of national health spending, growing in-
equity, and commercialization.1,2 This beneficial effect is mainly based on the assump-
tion that the general practitioner (GP) can serve as an effective gatekeeper. The GP acts 
as a coordinator of care, scrutinizing whether specialist treatment is necessary. If not, 
the patient can be reassured or a period of watchful waiting can commence. If specialist 
care is necessary, the GP can point out which specialist or health practice is best suited 
for provision. Another benefit is that GPs can offer basic treatments at low costs, with-
out the need for further specialist visits, and are less inclined than specialists and ther-
apists to engage in costly diagnostics or treatments. All in all, this implies that a strong 
position for the GP holds potential to reduce spending levels on health care. However, 
there are also reasons to believe a strong position for the GP could increase health care 
expenditure (HCE). If a disease that warrants specialist attention – such as cancer – is 
not diagnosed properly, a patient might not receive the necessary follow-up treatment, 
leading to a exacerbation of HCE later in life, or even fatality.3,4 On the other hand, GPs 
can also be responsible for inappropriate or unnecessary referrals, again leading to in-
creased HCE.5,6  
Research on the net effect of a strong position for GPs on HCE is scant and con-
tradictory. In two longitudinal analyses of health care costs in OECD countries, coun-
tries with a gatekeeping system were found to have slower growth in expenditure in 
some periods of time,7 or for ambulatory care only.8 A study performed in the US shows 
that health care utilization rates are lower in areas with relatively more GPs.9 Results 
from other studies suggest that strong primary care systems increase public health and 
decrease avoidable hospitalizations, but at the cost of higher levels of national health 
spending.10,11 In the Netherlands, frequent attenders to GPs (10% of GP visitors with 
the most visits) are found to have higher medical care expenses (MCE) when adjusting 
for possible confounding factors.12 A systematic review of literature on national gate-
keeping programmes yielded a small set of studies that incorporated HCE, which were 
found to be of poor quality.13  
In this study, we aim to estimate how the expenses for GP services relate to ex-
penses for health care services later in time. A database on 16,433 Dutch health insur-
ance clients aged 65 and older from July 2007 through 2010 was at our disposal to an-
alyse this association. We hypothesize that GP expenditure is inversely associated with 
expenses for other health care services later in time in a population of older people, 




when adjusting for baseline expenses for other health care services, socio-demographic 
characteristics, and time variables. Understanding the effect of the gatekeeping role of 
the GP on HCE is important in a time where policy-makers are urged to curtail ever 





With the aim to perform multiple studies on the association between the life situation 
of older people and their health care expenditure (HCE), the Leiden Health care Costs 
in Old Age (LHCOA) study was started in 2011. For this study, data on HCE of clients 
aged 65 and older in a period of 42 months were retrieved from a regional Dutch health 
care insurer (Zorg & Zekerheid) and matched with data on socio-economic characteris-
tics from Statistics Netherlands (Centraal Bureau van de Statistiek). Data were collected 
in the following steps: 
1. After consulting the IRB (legal department) of the regional health care insurer, 
data on medical care expenditure (MCE) were retrieved from the health care in-
surer’s management information system. Data were collected for the period July 
2007 through 2010 for all persons who lived in the regions where the health care 
insurer acted as the long-term care office, and who reached the age of 65 before 
2011. Addresses were linked with data on socio-economic status by postal code, 
provided by the Netherlands Institute for Social Research.  
2. In accordance with the IRB of the health care insurer, data on long-term care utili-
zation were collected from the EMEA Care Registration system (ECR), an infor-
mation system which offers an oversight of all the coded messages that are sent 
between organizations active within the confounds of the EMEA. ECR messages 
designating the start and end of long-term care provision were linked with na-
tional average fees per volume unit, provided by the Health Insurance Board. The 
received volume of extramural treatment were unknown, and no expenses could 
be calculated for this service type. 
3. After consulting the IRB of Statistics Netherlands a single transfer of data from the 
health care insurer to Statistics Netherlands was done over a secure line. CBS staff 
merged the data using citizen service numbers and dismissed any personal data 
afterwards. The authors could then only access the de-identified data in a secured 




room of Statistics Netherlands. The authors had no access to identifying infor-
mation. Any output destined for publication was first scrutinized by the IRB of Sta-
tistics Netherlands, so no output could be traced back to individuals. 
 
Study design 
The aim of this study was to investigate the effect of GP expenditure on expenses for 
other health care services later in time (oHCE). To capture a causal effect rather than 
just an association, we set up our study such that the outcome variable (oHCE) applied 
to a time period following that of the main determinant (GP expenditure). The mean 
follow-up per individual in the total study population (n=61,495) was ±36 months. GP 
expenditure was calculated over the first half (18 months) of follow-up. oHCE was de-
fined as the mean monthly HCE – except for GP services – after the first 18 months. The 
database should therefore consist of subjects with at least 19 consecutive months of 
follow-up (n=16,433).  
 
Statistical analyses 
It is plausible that a positive correlation between GP expenditure and oHCE is found 
when morbidity is not adequately adjusted for: patients with higher morbidity simply 
require more services, and will therefore have higher expenses with regard to all ser-
vices. However, because the health care insurer could not provide us with data on spe-
cific diagnosis codes of individuals due to privacy concerns, information on morbidity 
could not be acquired. Instead, we used ‘baseline health care consumption’ as a contin-
uous variable in our regressions models to adjust for confounding by morbidity. Base-
line health care consumption equals the monthly average of total expenses for all health 
care services except for GP care in the first 18 months of follow-up. A log scale was ap-
plied because of a lack of normal distribution. Log transformation resulted in a score 
ranging from 0 to 10 with a normal distribution. 
Besides baseline health care consumption, we included mortality (as a dummy 
variable), age, gender, marital status, socio-economic status, and calendar time as de-
terminants in our analysis. To measure the association between GP expenditure and 
oHCE, while adjusting for these other determinants, we used a generalized linear model 
(GLM) – either stand-alone or in a two-part model. A GLM had to be used to account for 
the skewed nature of the outcome variable. Two-part models needed to be used as a 
relatively large share of patients did not incur any expenses for some health care ser-
vices. We also applied these models to separate forms of HCE, like expenditure for hos-
pital care, or home care. The consequence of using two different models in our analyses 




is that the model predictions of expenses for different health care services could possi-
bly not completely add up to the prediction of oHCE. 
Health care services with a high share of zero expenses in the total study popu-
lation were hospital care (16.2%), home care (80.1%), care and nursing homes (92.6%), 
other forms of long-term care (95.4%), and total long-term care (75.2%). Low shares of 
zero expenses were observed in non-hospital forms of medical care (2.3%), total med-
ical care (1.9%), and oHCE (1.6%). We used a two-part model with logit model in the 





Table 1 shows the characteristics of the study population. In this study, because of our 
selection age, there are more women than men (61% vs. 39%). Overall, the subjects 
have a relatively high socio-economic status: 70% of the study population lives in an a 
postal area where the average socio-economic status is above the median. 
 


















 n (%) 
   
Gender   
Men – No. (%) 6,346 (39) 
Women 10,087 (61) 
   
Age   
65-79 12,228 (74) 
80+ 4,205 (26) 
   
Marital status   
Married 8,416 (51) 
Divorced 1,748 (11) 
Widowed 5,316 (32) 
Never married 953 (6) 
   
Socio-economic status   
Lower 4,850 (30) 
Higher 11,583 (70) 
   
Deceased during follow-up 1,354 (8) 
   




Table 2 shows the association of GP expenditure, socio-demographic variables, time 
variables, mortality, and baseline health care consumption with oHCE.  
 
Table 2. The association between GP expenditure and total other health care expenses 
later in time, corrected for socio-demographic characteristics, time variables, and base-
line health care consumption. Results are from a multivariate generalized linear model. 
1 Applies to the 19th month of follow-up and after. 
2 Applies to the first 18 months of follow-up.  
 
Expenditure for all health care 
services other than GP, 
later in time (=oHCE)1 
€/month 95% CI p 
    
GP expenditure2    
Per €10/month +74 +48 to +100 <.001 
    
Baseline health care consumption2    
Per level (ascending, total of 10) +301 +278 to +323 <.001 
    
Gender    
Male Ref   
Female −58 −113 to −4 .037 
    
Age    
65-79 Ref   
80+ +364 −294 to +433 <.001 
    
Marital status    
Married Ref   
Divorced +143 +60 to +225 .001 
Widowed +149 +86 to +212 <.001 
Never married +366 +257 to +374 <.001 
    
Socio-economic status    
Lower Ref   
Higher −97 −154 to −40 .001 
    
Calendar year    
2009 Ref   
2010 −4 −6 to −2 <.001 
    
Seasons    
Spring and summer Ref   
Autumn and winter +1 −2 to +4 .380 
    
Mortality    
Survived Ref   
Deceased +1,091 +880 to +1,303 <.001 
    




There is a significant association between GP expenditure and oHCE: for every 
€10/month of GP expenditure, there is a €74/month increase in oHCE (p<.001). Base-
line health care consumption also has a significant impact on oHCE, with €301/month 
for every level of health care consumption on a 10-point scale (p<.001). Overall, oHCE 
of women is lower than that of men (−€58/month; p=.037). oHCE of the older age group 
(aged 80 years and older) is €364/month higher than their younger counterparts (aged 
from 65 through 80 years). 
Subjects that are not or no longer married have higher oHCE than married sub-
jects: this is +€143/month for those divorced (p=.001), +€149/month for those wid-
owed (p<.001), and +€366/month for those never married (p<.001). Subjects with a 
higher socio-economic status have a lower level of oHCE (−€97/month; p=.001). If a 
subject dies during the second period of follow-up, his or her oHCE are €1,091/month 
higher than if he or she survives (p<.001). Calendar year has a very low but significant 
impact on oHCE (−€4/month lower in 2010 compared to 2009). Seasonal changes did 
not have a significant impact on health care expenses in this analysis. 
Table 3 shows a further specification of the associations between GP expenditure 
and expenses for different other health service types later in time, standardized for so-
cio-demographic variables, time variables, mortality and baseline health care consump-
tion. There is a significant association between GP expenditure and expenses for all 
other different health services later in time, and all associations are positive. 
 
Table 3. The association between GP expenditure and monthly expenses for 
other health care services later in time. 
Service type €/month 95% CI p 
    
All health care services other than GP +74 +48 to +100 <.001 
    
Medical care +37 +23 to +51 <.001 
Hospital +27 +18 to +36 <.001 
Other medical care +17 +10 to +24 <.001 
    
Long-term care +33 +25 to +42 <.001 
Home care +20 +15 to +25 <.001 
Care/ nursing home +15 +10 to +20 <.001 
Other long-term care +7 +4 to +10 <.001 
    
Shown is the change in health care expenses per month after the 18th month of follow-
up for every €10/month of GP expenditure in the first 18 months of follow-up, stand-
ardized for baseline health care consumption, mortality, socio-demographic charac-
teristics, and time variables. 
 
 




For every €10/month of GP expenditure, medical care expenses later in time are 
€37/month higher (p<.001), and long-term care expenses are €33/month higher 
(p<.001). When GP expenditure increases with €10/month, hospital expenses later in 
time increase with €27/month (p<.001). Expenses for other medical care services – 
such as medication, physiotherapy, and instrumental aids – increase with €17/month 
(p<.001). There is an increase in expenses for home care with €20/month (p<.001), for 
care and nursing homes with €15/month (p<.001), and for other long-term care ser-




We found that older people who have higher expenses for services from general prac-
titioners (GPs), in turn also have higher health care expenditure (HCE) for other health 
services later in time. All in all, for every ten euro spent on GP care, expenditure for 
other health care services later in time is €74 higher. The positive association can be 
explained by three dynamics. First, expenses for GPs are automatically associated with 
expenses for other health care services because patients often receive or even require 
a referral from the GP before receiving specialist health care. Second, GPs could increase 
the overall level of HCE by improper diagnoses or unnecessary referrals.3-6 However, 
we could not distinguish between necessary vs. unnecessary referrals, or improper vs. 
proper diagnoses. Third, the positive association may reflect health care ‘patterns’ in 
the population of older patients. In other words, it is possible that patients who visit 
GPs more often, have more health problems than those who visits GPs less frequent, 
and that these patients have higher expenses for GPs and the bulk of other health care 
services. 
The hypothesis we set out in the introduction – that GP expenditure is inversely 
associated with expenses for other health care services later in time in a population of 
older people, when adjusting for baseline health care consumption, socio-demographic 
characteristics, and time variables – was not corroborated by the results of our analysis. 
We reasoned that through selective referral to specialists, restricted use of costly diag-
nostics,16 watchful waiting,17 and the ability to provide basic medical services at lower 
expenses, the GP improves efficiency and allocation of hospital care. If such an effect is 
present, it is possible that we could not discern it because we lacked specific data, 
mainly in terms of morbidity.  
 Patients with a higher level of morbidity will make use both the GP and other 
health care services more often than those with a lower level of morbidity. If morbidity 




is not adequately adjusted for, it is a logical consequence that one will found a positive 
correlation between GP expenses and HCE for other services. In our analysis, we tried 
to adjust for morbidity by including baseline health care consumption and the risk of 
mortality in our analyses: both determinants will most likely rise when a subject’s mor-
bidity level is higher. Another reason to include mortality was the considerable impact 
of proximity to death on health care expenses.15,18-20 It cannot be ruled out that more 
specific data is needed to adequately account for morbidity, such as disease-specific di-
agnoses and severity of the diseases. Because the health care insurer could not provide 
us with data on specific diagnosis codes of individuals due to privacy concerns, such 
information on morbidity could not be acquired. 
The finding that married subjects and those with a higher socio-economic status 
have lower health care expenses than single subjects and subjects with a lower socio-
economic status confirms findings in other studies incorporating these determinants.21-
28 Calendar year was included as a determinant as this reflects the influence of changes 
in policy and health care prices, as well as general inflation. 
As our investigation could not ascertain a cause-and-effect association between 
the use of GP services and HCE for other services, further research is needed to answer 
the question whether GPs can curtail HCE. Specifically, more studies are needed that 
effectively account for morbidity. Further research is imperative, as the stability of 
many health systems are threatened by financial, demographic and cultural challenges, 
such as rising pressure on public finances, growing shares of older people, and increas-
ing patient demandingness. It has been suggested that the GP could play a pivotal role 




1. Starfield B, Shi L, Macinko J. Contributions of primary care to health systems and health. The 
Milbank Q. 2005; 83: 457-502. 
2. World health report 2008. Primary health care ─ Now more than ever. Geneva: World Health 
Organisation, 2008. http://www.who.int/whr/2008/en/. 
3. Bjerager M, Palshof T, Dahl R, Vedsted P, Olesen F. Delay in diagnosis of lung cancer in gen-
eral practice. Br J Gen Pract. 2006; 56: 863-8. 
4. Vedsted P, Olesen F. Are the serious problems in cancer survival partly rooted in gatekeeper 
principles? An ecologic study. Br J Gen Pract. 2011; 61: e508-e512. 
5. Jones-Elwyn G, Stott NC. Avoidable referrals? Analysis of 170 consecutive referrals to sec-
ondary care. BMJ. 1994; 309: 576-8. 
6. Naylor C, Imeson C. Referral management: Lessons for success. London: King’s Fund. 2010. 
http://www.kingsfund.org.uk/sites/files/kf/Referral-management-lessons-for-success-
Candace-Imison-Chris-Naylor-Kings-Fund-August2010.pdf 




7. Okunade AA, Karakus MC, Okeke C. Determinants of health expenditure growth of the OECD 
countries: Jackknife resampling plan estimates. Health Care Manag Sci. 2004; 7: 173-83. 
8. Delnoij D, van Merode G, Paulus A, Groenewegen P. Does general practitioner gatekeeping 
curb health care expenditure? J Health Serv Res Policy. 2005; 5: 22-6. 
9. Kravet SJ, Shore AD, Miller R, et al. Health care utilization and the proportion of primary care 
physicians. Am J Med. 2008; 121: 142-8. 
10. Macinko J, Starfield B, Shi L. The contribution of primary care systems to health outcomes 
within Organization for Economic Cooperation and Development (OECD) countries, 1970-
1998. Health Serv Res. 2003; 38: 831-65. 
11. Kringos DS, Boerma W, van der Zee J, Groenewegen P. Europe's strong primary care systems 
are linked to better population health but also to higher health spending. Health Aff. 2013; 
32: 686-94. 
12. Smits FT, Brouwer HJ, Zwinderman AH, et al. Morbidity and doctor characteristics only 
partly explain the substantial healthcare expenditures of frequent attenders: a record link-
age study between patient data and reimbursements data. BMC Fam Pract 2013; 14: 138. 
13. Garrido MV, Zentner A, Busse R. The effects of gatekeeping: A systematic review of the liter-
ature. Scand J Prim Health Care. 2011; 29: 28-38. 
14. Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in 
health econometrics. J Health Econ 1998; 17: 247-81. 
15. Wong A, van Baal PHM, Boshuizen HC, Polder JJ. Exploring the influence of proximity to death 
on disease-specific hospital expenditures: A carpaccio of red herrings. Health Econ. 2011; 20: 
379-400. 
16. Huibers L, Thijssen W, Koetsenruijter J, et al. GP cooperative and emergency department: an 
exploration of patient flows. J Eval Clin Pract. 2013; 19: 243-9. 
17. Van Bokhoven MA, Koch H, van der Weijden T, et al. The effect of watchful waiting compared 
to immediate test ordering instructions on general practitioners’ blood test ordering behav-
iour for patients with unexplained complaints; a randomized clinical trial 
(ISRCTN55755886). Implement Sci. 2012; 7: 29. 
18. Zweifel P, Felder S, Meiers M. Ageing of population and health care expenditure: A red her-
ring? Health Econ. 1999; 8: 485-96. 
19. Seshamani M, Gray AM. Ageing and health-care expenditure: The red herring argument re-
visited. Health Econ. 2004; 23: 217-35. 
20. Rolden HJA, van Bodegom D, Westendorp RGJ. Variation in the costs of dying and the role of 
different health services, socio-demographic characteristics, and preceding health care ex-
penses. Soc Sci Med. 2014; 120: 110-7. 
21. Van Lenthe FJ, Schrijvers CTM, Droomers M, Joung IMA, Louwman MJ, Mackenbach JP. Inves-
tigating explanations of socio-economic inequalities in health. The Dutch GLOBE study. Eur J 
Public Health. 2004; 14: 63-70. 
22. Yoo BK, Bhattacharya J, McDonald KM, Garber AM. Impacts of informal caregiver availability 
on long-term care expenditures in OECD countries. Health Serv Res. 2004; 39: 1971-92. 
23. Gaugler JE, Duval S, Anderson KA, Kane RL. Predicting nursing home admission in the U.S.: a 
meta-analysis. BMC Geriatr. 2007; 7: 13. 
24. Cai Q, Salmon JW, Rodgers ME. Factors associated with long-stay nursing home admission 
among the US elderly population: Comparison of logistic regression and the Cox proportional 
hazards model with policy implications for social work. Soc Work Health Care. 2009; 48: 154-
68. 




25. Luppa M, Luck T, Weyerer S, et al. Prediction of institutionalization in the elderly. A system-
atic review. Age Ageing 2010; 39: 31-8. 
26. Wong A, Elderkamp-de Groot R, Polder J van Exel J. Predictors of long-term care utilization 
by Dutch hospital patients aged 65+. BMC Health Serv Res. 2010; 10: 110. 
27. Stringhini S, Dugravot A, Shipley M, Goldberg M, Zins M, Kivimäki M, et al. Health behaviours, 
socioeconomic status, and mortality: further analyses of the British Whitehall II and the 
French GAZEL prospective cohorts. PLoS Med. 2011; 8: e1000419. 
28. Rolden HJA, van Bodegom D, Westendorp RGJ. Changes in health care expenditure after the 













Determinants on the micro-level: 


















The development, implementation and evaluation of a 
transitional care program to improve outcomes of 
frail older patients after hospitalization 
 
N. Heim*, H.J.A. Rolden*, E.M. van Fenema, A.W. Weverling-Rijns-burger, J.P. 
Tuijl, P. Jue, A.M. Oleksik, A.J. de Craen, S.P. Mooijaart, G.J. Blauw, R.G.J. Westen-
dorp, R.C. van der Mast, I.E.C. van Everdinck 










Under revision (Age & Ageing)






Background: A fragmented healthcare system appears badly suited to treat the in-
creasing number of older patients with multi-morbidity and complex care needs. Here 
we report on the development, implementation and evaluation of a regional transitional 
care programme aimed at improving outcomes of frail hospitalized older patients with 
complex care needs.  
Methods: The programme was drafted in co-creation with organizations representing 
older adults, care providers, and knowledge institutes. In a pre-post evaluation study, 
the incidence of adverse outcomes within three months after hospital admission, and 
long-term care expenses (LTCE) were compared. Patients aged ≥70 years, electively or 
acutely hospitalized in four hospitals in the targeted region, were included in the sam-
ple in 2010-2011 (pre) and 2012-2013 (post).  
Results: Developed innovations addressed (1) improved risk management;(2) delivery 
of integrated, multidisciplinary, function-oriented care; (3) specific geriatric interven-
tions; (4) optimization of transfers between centres. 891 and 1042 patients were in-
cluded in the two cohorts, follow-up data were available for 813 and 904 patients. The 
incidence of adverse outcomes in frail patients decreased from 49.2% (149/303) in co-
hort 2010-2011 to 35.5% (130/366) in cohort 2012-2013. The risk ratio (RR), adjusted 
for heterogeneity between hospitals, was 0.72 (95%CI:0.60-0.87). In non-frail patients 
the incidence of adverse outcomes was unchanged (RR: 1.02, 95% CI: 0.76-1.36). LTCE 
were similar in the two evaluation cohorts. 
Conclusions: The incidence of adverse outcomes was significantly reduced in frail 
older patients after the transitional care programme was carried out. The transitional 
care programme involving all regional stakeholders in integrated transitional care has 
led to feasible and cost-effective innovations of care for frail older patients after hospi-
talization. 
  






The proportion of patients that is admitted to hospitals with multiple interacting med-
ical conditions is increasing. This upturn is mostly caused by the fact that people, with 
and without diseases, live longer. The prevalence of multi-morbidity strongly increases 
with age and by the age of 65 years the majority of people suffer from multiple medical 
conditions.1 Nowadays healthcare is primarily delivered by highly specialized but frag-
mented disciplines. Current healthcare organizations offer adequate provisions for pa-
tients with a single medical condition that can be treated within the context of that spe-
cialized discipline. Frail patients with multiple medical, mental, social and/or cognitive 
problems, have far more complex care needs and require involvement of multiple spe-
cialties and disciplines.2 A fragmented healthcare system appears not well suited to 
treat older patients with multi-morbidity. The inadequacy of our current healthcare 
system is illustrated by the large proportion of older patients who experience loss of 
function and new dependency during and after hospitalization.3-6  
 In the Netherlands, the National Care for the Elderly Programme started in 
2008.7 The programme was designed to improve care for older adults with complex 
care needs by providing coherent integrated care that is better suited to the individual’s 
needs. The programme acknowledged that good care for older adults crucially depends 
on coordination between the various stakeholders involved. The programme did not 
exclusively focus on medical care, but encompassed the entire range of (health) care 
and assistive support available for older patients with complex needs. To start the nec-
essary innovation process, regional networks were formed in which all stakeholders 
involved in the care for older patients participated. It was the explicit intention that 
older adults themselves would participate in the design, implementation and evalua-
tion of the reforms as this was expected to have an additional value. 
 As part of the National Care for the Elderly Programme, a transitional care pro-
gramme was initiated in the region of Leiden. In co-creation with organizations repre-
senting older adults, a programme was drafted that aimed to improve patient-centred 
integrated care for frail older patients with complex care needs in transition. Joining 
forces at regional level, care providers, healthcare insurers and local authorities con-
ceived innovations and committed to the integrated transitional care programme. Spe-
cific actions were taken aimed to decrease the risk of functional decline and loss of in-
dependence after hospitalization. Here we report on the development and implemen-
tation of the transitional care programme and on its effects on the recovery of frail older 
patients after hospitalization.  






Design of the transition  
As an initial phase, we organized meetings with representatives of older adults and pa-
tients, and healthcare professionals of all healthcare organizations and authorities in 
the region. A representative of the national patient organization led the discussion to 
prioritize the objectives of the programme. These discussions led to the definition of 
the ‘Components of the transition’ stated in the left column of the table ‘Overview of 
innovations within the transitional care programme’.  
 
Management of the transition  
All organizations involved in the (health) care for older adults in the region were invited 
to participate in the programme. Four hospitals in the Leiden region - one academic 
hospital and three general hospitals - committed to make a transition. Each hospital 
established a committee with representatives of the target population (older adults) 
and of participating organizations in their area. During the programme, they assembled 
periodically to discuss issues concerning the quality of care of their collaborations and 
set targets for improvement of the quality of care (referred to as ‘aims’). These commit-
tees were encouraged to propose innovations within the context of the transition ad-
dressing shortcomings in their settings and collaborations (referred to as ‘specific defi-
ciencies’). The proposed innovations had to involve cooperation between at least two 
(health-) care providers. For each innovation, a professional of an organization involved 
was assigned to be the project manager responsible to implement the approved inno-
vations (referred to as ‘actions’). From the programmes’ resources, the healthcare pro-
viders involved were given budgets and support to execute the specific actions that 
were required.  
 
The evaluation study 
To assess whether frail older patients recovered more successfully after the transition, 
as compared to before the transition, we performed a pre post programme evaluation. 
We included two samples. In the first sample, the recovery of older patients after hos-
pitalization was assessed in 2010-2011 before the transitional care programme started. 
The second sample was used to evaluate whether the transitional care programme im-












Figure 1. Flow chart of the first evaluation cohort recruited in 2010-2011 included before the 




From October 1st 2010 until February 1st 2011 patients aged 70 years and over who 
were admitted to one of the four participating hospitals, were approached to enroll in 
the evaluation study. In three hospitals, both electively and acutely admitted patients 
in the orthopaedics, neurology, urology and general surgical departments were en-
rolled. In one hospital, only acutely admitted patients were approached to enroll inde-
pendent of the department to which they were admitted. Patients were eligible if they 
stayed in the hospital for at least two consecutive days and if they were approached 
within 72 hours after admission. Patients with cognitive impairments (Mini Mental 
State Examination <19) were excluded if no informal caregiver was available to provide 
information. Two years later, from October 1st 2012 until February 1st 2013, a second 
evaluation sample was enrolled applying the same methods.  
 
Measurements 
Trained nurses interviewed the subjects enrolled. The interview consisted of questions 
regarding demographics and a screening for frailty using a four domain approach in-




cluding function in activities of daily living (ADL) and risk assessments for under-nutri-
tion, falls and delirium.8 Three months after their admission date, subjects were sent a 
self-administered questionnaire by mail to measure their level of functioning.  
 
Screening for frailty  
During the interview, the risk on four domains was assessed: Activities in Daily Living 
(ADL)-disabilities, falls, delirium and under-nutrition. ADL-functioning was assessed 
using the Katz index on independence in ADL, a six item instrument to assess independ-
ency.9 Subjects were asked whether they needed help bathing, dressing, going to the 
toilet, transferring from bed to a chair and eating and whether they used incontinence 
materials (yes/no) two weeks before the interview. If two or more questions were an-
swered positively, subjects were considered to be limited in their function. A single 
question on whether the patient fell in the last six months (yes/no) was used to assess 
the risk for falls. The risk for the development of delirium was assessed using a score 
based on three questions: ‘Do you have problems with your memory?’, ‘Did you need 
help with self-care in the last 24 hours?’, and ‘Did you experience confusion during pre-
vious hospital admission or illnesses?’. If one or more of the questions was answered 
with ‘yes’, a patient was considered to have an increased risk for delirium. Nutritional 
status was assessed using the Short Nutritional Assessment Questionnaire (SNAQ).10 A 
patient was considered to have (an increased risk for) under-nutrition when he/she 
either lost 6 kg of bodyweight unintentionally or lost 3 kg unintentionally and had ei-
ther experienced a decreased appetite and/or used supplemental drinks or tube feed-
ing. We obtained a score by adding up the patients’ dichotomized screening results on 
the four subjects, resulting in a score ranging from 0-4. Patients were considered frail 
if aged 70 to 80 years and positive on three or four of the screened domains or when 
aged 80 years and over and scoring positive on one or more of the domains.11  
 
Outcome  
The outcomes of interest were the occurrence of an adverse outcome and the costs of 
long-term care three months after admittance in the hospital. Adverse outcome was de-
fined by death or a decline of ADL function and/or a high healthcare demand. Deaths 
were checked in the clinical record systems of the hospital and the healthcare insurer, 
or were reported by family members in response to receiving the follow-up question-
naire. A decline of ADL functioning was considered present when patients reported one 
or more additional ADL dependencies on the self-administered Katz ADL questionnaire 
after three months of follow-up. The healthcare demand was assessed using data from 
the information system of healthcare insurer in which the start and end of long-term 




care provision was registered. Patients were considered to have a high healthcare de-
mand if they received funding for a ‘care package’ designating sheltered residence with 
intensive care. For some patients we could only obtain information regarding mortality, 
and they were excluded. The patients of whom we received additional information (ei-
ther healthcare demand or ADL decline) were included.  
The effects of the programme on costs of long-term care in the 300 days follow-
ing a hospital admission were assessed. After consulting the IRB (legal department) of 
a regional health insurer, data on long-term care utilisation were collected from the Ex-
ceptional Medical Expenses Act (EMEA) Care Registration system (ECR), an information 
system which offers an oversight of all the coded messages that are sent between or-
ganisations active within the confounds of the EMEA. ECR messages designating the 
start and end of long-term care provision were linked with national average fees per 
volume unit, provided by the Health Insurance Board. The costs per volume of each ser-
vice type were calculated using the average fees per volume unit in 2012 in both cohorts 
to adjust for the influence of inflation and other price fluctuations. The volumes of ex-
tramural treatment received were unknown, hence no costs could be calculated for this 
service type. There were major changes in the financial compensation of long-term care 
rehabilitation between 2011 and 2013, resulting in incomplete data on this service type 
for cohort 2012-2013. Costs for this service type were therefore also excluded from the 
analysis. Data were available for 300 days after hospital admission. In the analysis, both 
the percentage of subjects enrolled in the evaluation sample receiving care as well as 
the average costs of care were evaluated.  
 
Statistical analyses  
Because the transition aimed to improve outcomes in frail older patients, all analyses 
were separately performed in the frail and the non-frail patients. Changes in the recov-
ery after hospitalisation over the course of the transition programme were analysed by 
calculating the risks for adverse outcomes in the sample included in 2012-2013 relative 
to the risk in the sample included in 2010-2011. To take differences between the hos-
pitals into account weighted risk ratios were obtained performing random effect anal-
yses using the metan function in Stata 12.0 (Stata-Corp, College Station, Texas, USA).  
 
Ethical approval  
Before the start of the study, the medical ethical committee of the Leiden University 
Medical Center decided that no formal ethical assessment of the protocol was necessary 
because the aim of the study was to evaluate the quality of care for (frail) older people. 
All patients received detailed written information before they were interviewed, and 









Content of the transitional care programme 
The four participating hospitals took on a leading role to organize and mobilize the 
stakeholders to improve the quality of care for older patients to prevent loss of inde-
pendence following a hospital admission. Other healthcare providers, i.e. general prac-
titioners, nursing homes, rehabilitation facilities and home care providers, soon joined 
the programme. During meetings led by the Federation of Patients and Consumer Or-
ganizations in the Netherlands (NPCF), older adults and healthcare professionals of all 
healthcare organizations in the region, prioritized the objectives of the programme. The 
discussion led to four main issues that all parties agreed on to need priority in the tran-
sition programme: (1) risk management; (2) delivery of integrated multidisciplinary, 
function oriented care; (3) specific geriatric interventions; (4) optimization of transfers 
between centres. 
 Issues concerning all healthcare organizations (of a certain type) in the region 
were centrally initiated in the transitional care programme. In the committees estab-
lished in the hospitals, representatives of healthcare providers proposed specific inno-
vations in the four components of the transition to tackle the deficiencies in the quality 
of care. The resulting programme is shown in table 1 and gives an overview of the con-
tent of the innovations targeting the four components of the transitional care pro-
gramme.  
 The progress on the agenda of the transitional care programme was monitored 
on several levels. Professionals of cooperative organizations gathered in different fre-
quencies in the committees established in each hospital. The professionals leading the 
implementation of the several innovations taken according to the agenda, held monthly 
meetings. The middle management congregated quarterly, while representatives of the 
board of all participating healthcare organization attended a meeting once a year.  




Table 1. Overview of transitions/ interventions in the transitional care programme. 
Specific deficiency Innovation Actions 
   
1. Risk management: Improve the identification of frailty in hospitalized older patients in order 
to be able to proactively intensify geriatric care and preventive measures in patients in need. 
No systematic identification of 
frailty in older patients was per-
formed in the four hospitals en-
rolled in the programme and pro-
active measures were not system-
atically taken. The hospitals did 
not have a proactively acting geri-
atric team.  
A feasible screening instru-
ment to identify frail older 
adults in an early stage of 
hospitalization was devel-
oped. The instrument was 
implemented in all four 
participating hospitals and 
follow-up interventions 
were designed. After a posi-
tive screening result, the 
need for an individualized 
care path is assessed. 
 A screening tool using a four 
domain approach (ADL func-
tion, under-nutrition, falls and 
delirium) was implemented.  
 Protocols were drafted for the 
follow-up of positive screen-
ing results. 
  Geriatric consultation teams 
were installed to follow-up on 
screening results and assess 
(the need for) individualized 
care paths. 
   
2. Delivery of integrated, multi-disciplinary and function oriented care: Develop pathways in 
which care is focused on improving, preserving and/or retaining physical function and independ-
ence, and is well accommodated between disciplines and centres. 
Acutely admitted older patients 
are an extremely frail group of pa-
tients. Because of complex prob-
lems, often combined with cogni-
tive disorders, the agreement be-
tween the multiple disciplines in-
volved in care for these patients is 
critical. In the acute phase, not all 
processes were well regulated 
and not all professionals in the 
hospital had enough knowledge 
on how to care for frail older pa-
tients.  
In one of the hospitals en-
rolled in the program, a sys-
tematic approach was 
taken to improve care for 
acutely admitted older pa-
tients. 
 All protocols and processes 
were evaluated, updated and 
new guidelines were con-
structed when needed. 
 Every unit appointed a nurse 
to be responsible to imple-
ment the protocols in his/her 
unit  
 Nursing and medical staff was 
educated on frailty in older 
patients. 
 Multidisciplinary meetings 
were held weekly, focusing on 
improving/preserving ADL-
functioning 
Older patients admitted for total 
knee or hip replacement need 
care of several disciplines and 
centres. Agreement between the 
multiple disciplines involved in 
the care for these patients is lack-
ing, which increases the risk for 
loss of function and independ-
ence. Because the patient is the 
only person involved in the whole 
care pathway, the patients’ per-
spective should be leading. 
The multidisciplinary mul-
ticentre care pathway for 
patients admitted for total 
knee or hip replacement 
was redesigned based on 
the patients’ perspective.  
 All protocols and processes 
were evaluated, updated and 
new guidelines were con-
structed when needed. 
 The agreement was improved 
between patient information 
concerning the care pathway 
handed-out by different 
healthcare providers 








Specific deficiency Innovation Actions 
   
2. Delivery of integrated, multi-disciplinary and function oriented care: Continued. 
No models for quality man-
agement of multicentre 
healthcare pathways were 
available. Monitoring, evaluat-
ing and improving quality of 
care within one healthcare or-
ganization is challenging, but 
when different organizations 
are involved in a pathway, the 
evaluation of the quality of the 
pathway gets even more com-
plicated.  
A model was developed 
to evaluate and improve 
multidisciplinary multi-
centre care pathways. 
Together, healthcare 
professionals involved 
in the CVA care path-
way in the region de-
fined and tested the 
model.  
 Seven substantive and measurable 
indicators of quality of care within 
the CVA care pathway were defined 
in agreement with all healthcare 
professionals  
 A dashboard was designed to visu-
alize whether the indicators met the 
norm. 
 In periodical meetings, cases were 
discussed and bottlenecks were 
identified and translated into points 
of improvement. These points were 
appointed to a professional respon-
sible to report on the progress in 
the next meeting.  
   
3. Specific geriatric interventions: Improve the security of the geriatric function around the 
patient, by developing agreement on responsibilities in geriatric care within the various disci-
plines and echelons, and develop a systematic approach of assessment of the type of care frail 
older patients need after discharge from the hospital. 
The evaluation of the optimal 
destination of discharge of pa-
tients was often done at the 
time treatment was finished 
and patients were ready for 
discharge. If a patient was in 
need of follow-up care, the 
discharge was often delayed 
because arrangements were 
still to be made. Also, profes-
sionals reported to have diffi-
culties with determining the 
optimal form of follow-up care 
in complex older patients.  
A triage instrument was 
developed. Profession-
als of different 
healthcare providers to-
gether decided on the 
best items to include in 
the instrument.  
 A triage instrument to determine 
the best discharge destination and 
follow-up care for patients in an 
early stage of hospitalization was 
developed. 
 A website was developed on which 
healthcare professionals could eas-
ily use the triage instrument  
 The feasibility of the instrument 
was tested in a pilot, concluding 
that its use stimulated the consider-
ation of factors influencing the 
needed care after discharge in an 
early stage. In delirious patients, 
timing appeared very influential 
and re-triage in a later stage often 
led to different conclusions. 




Table 1. Continued (2). 
 
  
Specific deficiency Innovation Actions 
   
3. Specific geriatric interventions: Continued. 
No existing setting for rehabil-
itation was available for pa-
tients with cognitive problems 
that newly manifested during 
hospitalization. These patients 
frequently stayed in hospital 
longer than necessary, their 
cognitive problems worsened 
and their rehabilitation was 
harmed.  
A special rehabilitation 
unit was opened in a 
nursing home for pa-
tients with a newly 
manifested cognitive 
disorder during hospi-
talization in order to 
achieve sooner dis-
charge from the hospi-
tal to a well suiting en-
vironment. 
 A unit in a nursing home was com-
pletely refurbished to meet the 
needs of patients with cognitive 
disorders and a rehabilitation 
need. 
 Staff of the rehabilitation unit was 
educated to be better able to care 
for early discharged patients to en-
able patients to be transferred to 
the well suiting unit sooner.  
 The assessment of the eligibility of 
patients to be admitted to the reha-
bilitation unit was done by a geri-
atric nurse in close cooperation 
with the specialists in the hospital 
and nursing home.  
 The geriatrician from the hospital 
held weekly consultation visits to 
(the transferred patients in) the 
nursing home. 
Older patients were fre-
quently referred to the hospi-
tal for the analyses of falls, 
while the problems these pa-
tients have could often be 
treated by a general practi-
tioner (GP) specialized in the 
care for older patients. This 
form of care better secures 
the geriatric function of pa-
tients, is more comfortable for 
patients and costs less.  
An outpatient unit for 
the analyses of falls 
was outplaced from 
the hospital setting to 
the primary care set-
ting.  
 In the first phase, the outpatient 
unit in the GPs’ office was staffed 
by both the GP and a geriatrician 
from the hospital, the GP-assistant 
and a geriatric nurse from the hos-
pital and physiotherapists both 
from the primary setting as from 
the hospital.  
 Knowledge was transferred be-
tween the disciplines and agree-
ment was reached as for which pa-
tients should be referred to the 
hospital for a more comprehen-
sive assessment.  
 GPs in the region were instructed 
which patients to refer to the out-
patient unit at the specialized GP 
and which to the hospital.  




Table 1. Continued (3). 
 
Appraisal of recovery after hospitalization 
To appraise the risk of loss of physical function and independency after hospitalization 
as well as the impact of the transitional care programme we compared two representa-
tive cohorts: a cohort of patients included from 2010 through 2011 before implemen-
tation of the programme, and a second cohort from 2012 through 2013 after implemen-
tation of the transitions.  
Specific deficiency Innovation Actions 
   
4. Risk management: Improve the identification of frailty in hospitalized older patients in order 
to be able to proactively intensify geriatric care and preventive measures in patients in need. 
When a patient was trans-
ferred from one healthcare 
provider to another, im-
portant information about the 
patient and the treatment was 
often lacking. It took a lot of 
time and effort to get a com-
plete picture of the patient 
and the care and treatment 
needed. Lacking information 
hampered the rehabilitation 
process. 
Representatives of all 
healthcare providers in the 
region cooperated to define 
which information each or-
ganization/ professional 
needs from their predeces-
sor to optimally continue 
care at the time a patient is 
transferred. A digital sys-
tem to send data to the next 
healthcare provider was 
implemented. 
 A uniform set of minimal infor-
mation healthcare providers 
require at the time of a transfer 
was developed.  
 Based on a business case, all 
big healthcare providers in the 
region together acquired a digi-
tal transfer system to transfer 
the required information digi-
tally.  
 Each organization appointed 
staff members to be responsi-
ble for the internal implemen-
tation of the digital transfer 
system. These professionals 
held meeting to discuss optimi-
zation of the system. 
An effort to improve multi-
centre care for CVA-patients 
was made in the months prior 
to the start of the RCP. It was 
observed that the new proto-
cols and procedures were not 
all well implemented yet. Es-
pecially, getting every profes-
sional involved to use the 
same methods to facilitate the 
rehabilitation process was 
challenging.  
Trained nurses were hired 
to make an extra effort in 
improving the multidisci-
plinary multi-centre care 
pathway for stroke pa-
tients. 
 Expertise was shared and mu-
tual understanding and agree-
ment was increased through 
the exchange of staff between 
the different units of the 
healthcare organizations in-
volved (hospital, nursing 
home, rehabilitation centre). 
 The trained nurses collabo-
rated on the units to educate 
staff of the organizations in-
volved to work according to 
the newly implemented meth-
ods to facilitate rehabilitation. 
They organized clinical les-
sons, but mostly trained staff 
by ‘training on the job’. 




In the two cohorts of patients, 813 and 904 patients could be included in the analyses 
of adverse outcomes after three months of follow-up. From 721 and 827 patients who 
filled out and returned the self-administered questionnaire after three months of fol-
low-up, data on functional decline were complete. Data on healthcare demand three 
months after hospital admission were complete for 713 and 785 and data on mortality 
were complete for 816 and 916 patients, in the two cohorts respectively. 
In table 2, baseline characteristics of the frail and non-frail subjects of cohort 
2010-2011 and 2012-2013 are displayed separately.  
 
Table 2. Baseline characteristics of the frail and non-frail subjects of the evaluation 
samples.  
a ADL = Activities of daily living. ADL limitations: Katz index on independence (range 0-6). 
b Risk for delirium: VMS Delirium (range 0-3), an increased risk was present if scored ≥1. 
c Risk for malnutrition: VMS malnutrition (lost weight and/or both less appetite as well as energy 
supplement use). 
 
In the cohorts, the prevalence of frailty was 38.0% and 41.6%, respectively. Within the 
strata of frailty, most characteristics were well comparable between the cohorts. Of the 
frail patients in cohort 2010-2011, 49.2% suffered an adverse outcome, in the 2012-









      
Number 339 432  552 610 
Sex (% male) 39.2 42.8  51.1 51.3 
Age (median (IQR)) 83 (7) 83 (7)  74 (6) 74 (5) 
Hospital      
I 31.9 21.1  27.4 19.7 
II 18.6 22.2  8.7 12.1 
III 29.2 41.0  46.4 44.3 
IV 20.4 15.7  17.6 23.9 
Acute admissions (%) 61.9 62.0  32.0 35.0 
ADL limitations prior to  




Falls in last 6 months (%) 63.1 59.4  23.2 20.2 
Risk for delirium (%)b 85.3 87.5  35.7 55.6 
Risk for malnutrition (%)c 46.3 43.1  15.4 16.2 
Specialty (%)      
Orthopaedics 22.8 24.1  30.6 33.0 
Surgery 41.5 34.7  33.6 32.1 
Neurology 16.9 16.0  12.0 12.1 
Urology 12.2 8.1  18.2 13.1 
Other 6.6 17.1  5.3 9.7 
      




2013 cohort that percentage decreased to 35.5%. In the non-frail subjects the percent-
age of adverse outcomes was similar in both cohorts (14.9% and 14.7% respectively).  
 Figure 2 shows the lower risk for adverse outcomes in frail patients admitted to 
hospital in the period 2012-2013 as compared to period 2010-2011. The overall 
weighted estimated relative risk of all frail patients in the cohort 2012-2013 was 0.72 
(95% CI: 0.60-0.87). Furthermore, the figure shows that the tendency for a reduced risk 
for adverse outcomes was seen in all separate components of the composed outcome 
(death, decline of ADL function and high healthcare demand). In non-frail patients, the 
risk for adverse outcomes did not change in any of the hospitals (overall RR: 1.02, 95% 




Figure 2. Relative risks for an adverse outcome in frail (left panel) and non-frail (right panel) 
older patients before and after the implementation of the transition care programme. Risk ratios 
of the four participating hospitals are presented separately. The relative risks for adverse out-
come displayed with the black squares, as well as specific adverse sequelae are derived from es-
timated weighted, random effects analysis.  
 
 
Appraisal of the effect on costs of long-term care 
The percentage of the subjects enrolled in the evaluation sample that received care in 
the 300 days after hospital admission is shown in the left panel of figure 3. In the first 
58 days after hospital admission, use of professional care was more prevalent in the 
sample enrolled in 2012-2013. During the rest of the follow-up period, there was no 
difference in care usage between the samples evident and the area under the curves 
was similar. The right panel of figure 3 shows the average daily costs of care of both 
samples in the 300 days after hospital admission. In the first six months after hospital 




admission, the average costs per subject were lower in cohort 2012-2013. After six 
months, costs became higher in cohort 2012-2013. Overall, there was a non-significant 
mean difference of €0.10 per subject per day favoring the cohort 2010-2011. 
 
 
Figure 3. Number of people using long-term care after hospitalisation (a) and average costs for 





This pre post evaluation showed an improvement in outcomes for frail older hospital-
ized patients through the implementation of a transitional care programme. Within a 
commonly agreed framework, the various organizations involved had adapted the 
measures to their own organizations. It was shown that frail patients who were being 
hospitalized after the programme was implemented recovered more successful, while 
the costs of long-term healthcare remained unchanged.  
 
Strengths and weaknesses of the evaluation study  
The shared decisions between the partners as well as the continuously implemented 
changes in the delivery of healthcare made it impossible to conduct a randomized trial. 
Organizational interventions like the transitional care programme, do not allow for a 
timeframe sufficient to engage in such a trial, because quality improvement is a contin-
uous process and changes in healthcare delivery occur faster than results of research 
are available.12 The changes in the delivery of healthcare apply to all (older) patients to 
a greater or lesser extent. We do not know which patients included in the evaluation 
sample were treated according to which part of the programme and what measures 




they benefitted from. This way, the changes in the recovery that were found in our eval-
uation sample represent the changes that can be expected in the whole target popula-
tion of hospitalized frail older patients. By including large samples of patients from all 
four hospitals in the region and not applying strict exclusion criteria, we aimed to in-
clude a population representative of all frail patients targeted by the programme. How-
ever, participating in the interview might have been too burdensome for the frailest 
patients and they might be under represented. Because the measures taken in the pro-
gramme targeted especially the frail patients, it is presumable that they would not ben-
efit less from the measures taken than the included population. A weakness of the eval-
uation of the effects of the programme on costs of long-term care, is the absence of data 
on costs for long-term rehabilitation, which unfortunately could not be included in our 
economic analysis. We expect that a cost reduction due to improved recovery after hos-
pitalization is most visible in this sector.  
 
Comparison of the programme to previous work 
A local knowledge institute took on a leading role to entice all care providers in the 
region to participate in the transition care programme. Collectively, the agenda of nec-
essary actions to improve quality of care was determined by all partners. This cooper-
ation brought about the commitment of healthcare providers and assured that the urge 
to improve quality of care was felt and shared by all partners. Leadership and the bot-
tom-up design of measures, have been previously argued to be of utmost im-
portance.13,14 Others emphasized the importance of incorporating practices and expec-
tations of healthcare professionals and managers in the design of measures.9 These fac-
tors might added to the effectiveness of our programme, as the professionals were em-
inently involved in all initiatives. The measures proposed were adapted to fit the needs 
of the individual organizations. The development of tailor made measures allowed the 
necessary flexibility to enhance implementation in the different organizations. Making 
the healthcare providers themselves responsible for the implementation of the 
measures in their organizations and collaborations, facilitated the permanent establish-
ment of measures. Finally, the patient centeredness of measures was enhanced by in-
cluding older patients in the hospital committees. 
 
Conclusions 
Within the transitional care programme, we achieved to get commitment from the 
healthcare providers of different disciplines by co-creating the measures within the 
transition. The sustainable establishment of the innovations was enhanced by making 




providers responsible to implement the measures in their care provision. Further re-
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Background: In ageing populations, informal care holds great potential to limit rising 
health care expenditure. The majority of informal care is delivered by spouses. The loss 
of informal care due to the death of the spouse could therefore increase expenditure 
levels for formal care.  
Objective: To investigate the impact of the death of the spouse on health care expendi-
ture by older people through time. Additionally, to examine whether the impact differs 
between socio-demographic groups, and what health services are affected most. 
Design: Longitudinal data on health care expenditure (from July 2007 through 2010) 
from a regional Dutch health care insurer was matched with data on marital status 
(2004-2011) from the Central Bureau of Statistics. Linear mixed models with log trans-
formed health care expenditure, generalized linear models and two-part models were 
used to retrieve standardized levels of monthly health care expenditure of 6,487 older 
widowed subjects in the 42 months before and after the loss of the spouse.  
Results: Mean monthly health care expenditure in married subjects was €502 in the 42 
months before the death of the spouse, and expenditure levels rose by €239 (48%) in 
the 42 months after the death of the spouse. The increase in expenditure after the death 
of the spouse was highest for men (€319; 59%) and the oldest old (€553; 82%). Ex-
penditure levels showed the highest increase for hospital and home care services (to-
gether €166).  
Conclusions: The loss of the spouse is associated with an increase in health care ex-
penditure. The relatively high rise in long-term care expenses suggests that the loss of 
informal care is an important determinant of this rise. 
 
  





In many developed countries, population ageing can be directly related to a rise in 
health care expenditure. In the Netherlands, for example, the share of people aged 65 
and above is expected to increase from 15% in 2008 to 26% in 2040 and health care 
expenses increase exponentially after the age of 65.1,2 Although higher levels of health 
care expenditure are associated with old age, older people also hold potential to limit 
expenditure levels. By offering informal care, older people keep their partners, family-
members, friends or neighbours away from the health care sector. Not much known is 
about the economic value of this preventive role of the older population.  
It is plausible that informal care from spouse to spouse accounts for the biggest 
share expenditure prevention. It has been found that women offer the highest share of 
informal care, either as wives or daughters.3 The contribution of men rises with age, 
and relates mainly to spouses.4 Several authors have found that having a partner signif-
icantly decreases older people’s risk of utilizing nursing home services.5-9 However, 
these studies do not include expenditure levels and often do not look at the use of other 
health care services. The economic value of spousal informal care can be estimated by 
observing the difference in health care expenditure by people with a spouse with that 
of people who have no spouse, or no longer have a spouse. It has been found that the 
death of a spouse increases subsequent mortality risk,10-12 health risks,13 risk of long-
term care utilization,14,15 and medical care utilization.16 In a study of 61 widows and 
widowers by Prigerson et al. (2000) it was estimated that widowed persons in the 
United States incurred up to 60% more health care expenditure than married persons.17 
Besides the observation in this small study, the effect of the death of the spouse on 
health care expenditure through time remains largely unknown. 
Therefore, in a large and complete dataset of Dutch health care expenditure, we 
have investigated the impact of the death of the spouse on health care expenditure 
through time. We collected figures of individual health care expenditure within a large 
population over a long period of time from the database of a health care insurer, and 
linked this information with data on marital status. First, we analysed the effect of hav-
ing a spouse and other socio-demographic determinants on health care expenditure in 
our total study population. Second, we focused only on clients who became widowed, 
and observed if individual levels of health care expenditure change before and after the 
death of the spouse. We also discerned whether there is a difference in this effect be-
tween men and women, younger and older people, and people with a lower and higher 
socio-economic status. Third, we investigated how expenditure levels for different 




health services change before and after the death of the spouse. Insight into the eco-
nomic value of formal care prevention by spouses is important for policy-makers who 
are concerned with improving the lives of older people and who are, at the same time, 





After consulting the internal review board (IRB) of the regional health insurer, data on 
health care expenditure was retrieved from a health insurer. A formal waiver of IRB 
approval was received from the Central Bureau of Statistics (CBS) for data collection. 
After consulting the IRB of the CBS a single transfer of data from the health insurer to 
the Central Bureau of Statistics (CBS) was undertaken over a secure line. A formal 
waiver was received by the IRB of the CBS. After the data transfer, the CBS first removed 
any personal data. The leading author could then only access the de-identified data in a 
secured room of the CBS. The authors had no access to identifying information. Any 
output destined for publication was first scrutinized by the IRB of the CBS, so no output 
could be traced back to individuals. No data is publicly available. Data collection and 
analysis was in full accordance with privacy legislation and protocol. 
 
Data 
With the aim to perform multiple studies on the association between the life situation 
of older people and their health care costs, the Leiden Health care Costs in Old Age 
(LHCOA) study was started in 2011. For this study, data on health care expenditure for 
61,495 people aged 65 and older in a period of 42 months were retrieved from a re-
gional Dutch health insurer (Zorg & Zekerheid) and matched with data on socio-eco-
nomic characteristics from the Central Bureau of Statistics (CBS). Data were collected 
in the following steps: 
1. After consulting the internal review board (IRB) of the regional health insurer, 
data on medical care expenditure were retrieved from the health insurer’s man-
agement information system. Data were collected for the period July 2007 through 
2010 for all persons who lived in the regions where the health care insurer acted 
as the long-term care office, and who reached the age of 65 before 2011. Addresses 
were linked with data on socio-economic status by postal code, provided by the 
Netherlands Institute for Social Research. 
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2. Collecting data on expenditure for separate medical care services proved to be 
highly time consuming. These data were only retrieved for a subpopulation, ran-
domized for socio-economic status. Eight separate services were identified: gen-
eral practice, hospital, pharmacy, allied health care, psychology, instrumental aids, 
dental care, and other medical care. 
3. In accordance with the IRB of the health insurer, data on long-term care utilization 
were collected from the EMEA Care Registration system (ECR), an information sys-
tem which offers an oversight of all the coded messages that are sent between or-
ganizations active within the confounds of the EMEA. ECR messages designating 
the start and end of long-term care provision were linked with national average 
fees per volume unit, provided by the Health Insurance Board. The received vol-
umes of extramural treatment were unknown, and no expenses could be calcu-
lated for this service. 
4. After consulting the IRB of the CBS a single transfer of data from the health insurer 
to the CBS was done over a secure line. CBS staff merged the data using citizen 
service numbers and dismissed any personal data afterwards. The authors could 
then only access the de-identified data in a secured room of the CBS. The authors 
had no access to identifying information. Any output destined for publication was 
first scrutinized by the IRB of the CBS, so no output could be traced back to indi-
viduals. No data is publicly available. Data collection and analysis was in full ac-
cordance with privacy legislation and protocol. Socio-demographic variables col-
lected at the CBS were: age, gender, marital status, and time of death.  
5. After these steps, the total study population comprises 61,495 subjects. Expendi-
ture for separate medical care services are known for 18,995 subjects. 
 
A more detailed description of the data collection procedure can be found in supple-
mentary figure 1 (page 102), which presents a flowchart of the procedure. 
 
Statistical analysis 
In the overall analysis, we used the total study population (n=61,495) to investigate 
what influence gender, age, marital status, socio-economic status (SES), and calendar 
year have on monthly health care expenditure (HCE). All determinants are defined as 
categorical variables. We defined two groups for age (65-79 years old, and 80 years and 
older) and SES (score < 6.45 and score ≥ 6.45) based on the medians (age=77 years; SES 
score=6.44). As there are multiple monthly observations for each subject in our dataset, 
and HCE is skewed to the right, leptokurtic and heteroskedastic, we used a linear mixed 
model with a log transformation of HCE (LLMM). Visual inspection of the distribution 




of the residuals in the model now showed a normal distribution. The model can be ex-
pressed with the following equation: 
 
1 	
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where H stands for HCE for individual i in month j, G for gender, AG for age group, M for 
marital status, SG for socio-demographic status group, and Y for calendar year. To esti-
mate the effect of each determinant in the equation, we calculated the exponential func-
tion of each β in the equation. 
Hereafter, the focus was shifted to the subjects who became widowed in the pe-
riod 2004-2011 (n=6,487). Data on marital status was available for a longer time period 
(2004-2011) than data on HCE (July 2007-2010). This way, we could measure the im-
pact of the death of the spouse on HCE with a maximum time span of 42 months before 
and 42 months after the month in which the subjects became widowed. A LLMM was 
used to estimate HCE for every month. Standardization was applied for socio-demo-
graphic variables and calendar year by holding them constant on the mean. Monthly 
point estimates of HCE before and after the loss of the spouse were also calculated for 
different socio-demographic groups: both genders, two age groups, and two socio-eco-
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where H stands for HCE for individual i in month j (j =  ̶42 to +42), G stands for gender, 
A for age, S for socio-demographic status score, Y for calendar year, and MW for each 
month before or after widowhood. 
Monthly points estimates will provide eye evidence on a possible effect of wid-
owhood on HCE. To test whether the level of HCE during widowhood differs signifi-
cantly from the period before widowhood, we compared the mean monthly levels of 
both periods in a two-sample t-test. The means of HCE for each period were calculated 
from the estimates from the LLMM (equation 2). 
In analysing the effect of the loss of the spouse on expenditure levels in specific 
health services, we selected subjects for whom expenditure were known for each sepa-
rate medical care service and who became widowed from 2004 to 2011 (n=2,027). For 
some health services, only a relative low number of subjects received care. As the out-
come variables were thus not only characterized by problems with skewness, kurtosis 
and heteroskedasticity, but also with a high share of zero values, a LLMM could not be 
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applied. Therefore, we first pooled monthly expenses of each health service for every 
subject, and then used either a generalized linear model (GLM) or two-part model 
(2PM) with a logit model for the first part, and a GLM with gamma distribution and a 
log link for the second part.18,19 The GLM can be expressed as: 
 
3 	  = !	 =  +   +   +    +   +  
 
where  is the link function, and T stands for average monthly expenditure for a specific 
health service for individual i in period p, G stands for gender, A for average age, S for 
socio-demographic status, and Y stands for average calendar year. The 2PM is ex-
pressed as: 
 
4 #	 $%	 
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where ,& expresses the set of determinants, and η the GLM (see equation 3 for ,& and 
η). For each health service, comparison of the average monthly expenditure levels be-
fore the loss of the spouse with the average level after the death of the spouse was per-




The study populations 
The descriptive statistics of the total study population, the widowed population and the 
widowed subpopulation can be found in table 1. First, we analysed the effects of socio-
demographic characteristics on health care expenditure (HCE) in the total population 
(n=61,495). Hereafter, we included those subjects who lost their spouse in the period 
2004-2011 to investigate the impact of the death of the spouse on HCE (n=6,487). The 
majority of these widowed subjects are women (71%). The average follow-up before 
the death of the spouse is 11.6 (±14.6) months, and after the death of the spouse 16.8 
(±12.8) months, both with a maximum of 42 months. For the analysis concerning ex-
penditure for different health services, a widowed subpopulation was used (n=2,027). 


















 Number (%)  Number (%)  Number (%) 
         
Study population 61,495   6,487   2,027  
         
Gender         
Men 24,904 (40%)  1,854 (29%)  590 (29%) 
Women 36,591 (60%)  4,633 (71%)  1,437 (71%) 
         
Age         
65-79 39,113 (64%)  4,729 (73%)  1,442 (71%) 
≥ 80 12,010 (20%)  1,758 (27%)  585 (29%) 
         
Marital status         
Married 35,291 (57%)  3,139 (48%)  991 (49%) 
Widowed 16,819 (27%)  3,348 (52%)  1,036 (51%) 
Divorced 5,742 (9%)  - -  - - 
Never married 3,643 (6%)  - -  - - 
         
Socio-economic status (SES)         
Lower (SES score < 6.45) 30,633 (50%)  3,288 (51%)  1,232 (61%) 
Higher (SES score ≥ 6.45) 30,862 (50%)  3,199 (49%)  795 (39%) 
         
a Descriptive statistics are all baseline figures. 
 
Effects of socio-demographic characteristics on health care expenditure 
Table 2 shows the impact socio-demographic determinants have on HCE in the total 
study population (n=61,495). In the total population, mean monthly health care ex-
penditure is €629. The level of HCE for widows and widowers is €329 higher than for 
married people, which equals 52% of the mean. HCE for divorced subjects is €49 (8%) 
higher, and for those never married HCE is €196 (31%) higher compared to married 
subjects. On average, women have €20 (3%) more HCE per month than men, and sub-
jects of 80 years or older have €316 (50%) more HCE than their younger counterparts. 
Expenditure levels are €25 (4%) lower for subjects with a higher socio-economic status 
than for subjects with a higher socio-economic status.  
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Table 2. The effect of socio-demographic characteristics 
on health care expenditure (HCE) in the total study pop-
ulation (n=61,495), from July 2007 through 2010. Aver-




   
Gender   
Men Ref  
Women +20   .002 
   
Age    
65-79 Ref  
80+ +316 <.001 
   
Marital status   
Married Ref  
Widowed +329 <.001 
Divorced +49 <.001 
Never married +196 <.001 
   
Socio-economic status (SES)   
Lower SES group Ref  
Higher SES group –25 <.001 
   
a Results are coefficients and their p-value from a linear mixed 
model with log transformation.  
 
The effect of the death of the spouse on health care expenditure 
In the second analysis, we only focus on the subjects who became widowed in the pe-
riod 2004-2011. As can be seen from figure 1 (upper panel), HCE rises gradually before 
the loss of the spouse and shows a steep increase in four months around the month the 
spouse died. The month in which a subject became widowed is defined as ‘month 0’, 
and depicted as a vertical dotted line. 
After the initial rise in HCE after the death of the spouse, there is a slight decline 
in HCE. As these results are unstandardized, results could be influenced by a rise in the 
mean age, changing shares of men vs. women and lower vs. higher socio-economic clas-
ses, as well as rising health care prices. For this reason, we regressed the monthly HCE 
on the months before and after the death of their spouse in a linear mixed model with 
log transformation. 
 





Figure 1. Monthly health care expenditure (HCE) before 
and after death of the spouse (n=6,487). The upper panel 
represent the raw data. The lower panel is from a linear 
mixed model with log transformed HCE, standardized for 
gender, age, socio-economic status, and calendar year. 
 
Figure 1 (lower panel) shows the monthly point estimates from the regression model, 
standardized for age, gender, socio-economic status score, and calendar year. With 
standardization, HCE shows no more gradual rise before the loss of the spouse, and no 
slight decline afterwards. There is a sudden increase in HCE of €207 (36%) in the month 
the subjects lose their spouse. 
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Figure 2 shows the monthly points estimates of HCE in the months before and after the 
loss of the spouse for both genders (panel a), two age groups (b) and two SES groups 
(c). The expenditure level of men rises to a higher level after the death of the spouse 
than for women. After the loss of the spouse, men have a continual increase in HCE, 
while the level of women remains more stable. Individuals in the older age group have 
higher levels of HCE than their younger counterparts before and during widowhood. An 
increase in monthly HCE starts to set in earlier for the older age group (around 7 
months before death of the spouse) than for the younger age group, for which no real 
increase in HCE is noticeable prior to widowhood. Widowed subjects in the lower SES 
group require slightly less HCE before and after the death of the spouse. Individuals of 
a higher socio-economic class have a small, continual rise in HCE after the death of the 
spouse. 
The mean levels of HCE in the 42 months before and after the loss of the spouse 
in the widowed population, and different socio-demographic groups, are shown in table 
3. Overall, HCE is €239 higher in the 42 months after the death of the spouse than in the 
42 months before, which is equal to a rise of 48% (p=.01). With €319 (59%; p=.116) 
the rise in HCE is higher for men than for women (€209; 43%; p=.042). When still mar-
ried, individuals in the older age group have higher levels of HCE (€678) than their 
younger counterparts (€381). This difference further increases after the death of the 
spouse: HCE for the older age group rises with €553 (82%; p=.028) and for the younger 
age group with €124 (32%; p=.12). The level of HCE for individuals from the higher 
socio-economic group is higher before and after the death of the spouse, but the relative 
increase due to widowhood is lower (45% vs. 50%). However, this rise in HCE after the 
death of the spouse is not significant for both socio-economic groups. 




Figure 2. Monthly health care expenditure before and after the death of the spouse for both 
genders (a), two age groups (b) and two SES groups (c). Point estimates are from a linear 
mixed model with log transformed health care expenditure, standardized for gender, age, so-
cio-economic status and calendar year. 
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Table 3. Differences in health care expenditure (HCE) in the 42 months before and after 
death of the spouse (population of widowed subjects, n=6,487).  
a Mean monthly levels of HCE are from a linear mixed model with log transformed HCE, stand-
ardized for gender, age, socio-economic status, and calendar year (see figure 1 and 3).  
 
The effect of the death of the spouse on expenditure for separate health services 
In table 4, the association between HCE and widowhood over time is shown for each 
health service in a subpopulation of 2,027 widows and widowers. With €271 
(56%;p<.001) the overall effect size of the death of the spouse on HCE is similar to the 
total widowed population. The rise in the absolute level of expenditure levels after the 
death of the spouse is slightly larger in the medical care (€140; p<.001) sector than in 
the long-term care sector (€131; p<.001). However, the relative rise is five times 
smaller in the medical care sector than in the long-term care sector (30% versus 157%). 
Expenditure for nursing home care shows the highest relative increase after the death 
of the spouse with 163%, although this increase is not significant (p=.057). Expenditure 
for hospital services increases the most in the absolute sense (€110 per month; p<.001). 








Mean monthly HCE (€)a  Difference 
Before death 
of the spouse 
After death 
of the spouse  
€ % p 
      
All 502 741 239 48 .010 
      
Gender      
Men 540 859 319 59 .116 
Women 489 698 209 43 .042 
      
Age      
65-79 381 505 124 32 .120 
80+ 678 1231 553 82 .028 
      
Socio-economic status      
Lower SES group 469 703 234 50 .056 
Higher SES group 539 784 245 45 .077 
      




Table 4. Differences in health care expenditure (HCE) in the 42 months before and 
after the death of the spouse for separate health services, standardized for gender, 
age, socio-economic status and calendar year (subpopulation of widowed subjects, 
n=2,027).  
a Results are from a generalized linear model (GLM). 
b Results are from a two-part model with logit model in the first part, and GLM in the second. 
c Dental care, allied health care, mental health care, transportation, instrumental aids, acupunc-
ture, and others. 
d Long-term rehabilitation, palliative care, care for the disabled, and long-term mental health care. 
 
Marriage protection, marriage selection, a shared environment, bereavement 
Since spouses can provide each other with intensive levels of informal care, one could 
argue that marriage has preventive effects on formal care use. Although the loss of a 
spouse is treated as an exogenous shock, different endogenous factors could be at play 
in the association between widowhood and health care expenditure. One could argue 
from a marriage selection perspective.20 People tend to select their spouse on the basis 
of similar characteristics, such as age, intelligence, educational level, and psychological 
well-being.21,22 Because spousal partners are similar in these traits, it is likely that their 
health care expenditure levels also show similar patterns over time, regardless of life 
events. Another plausible explanation is that married couples share a similar environ-
ment and are thus susceptible to equal risk factors.23 Both effects cause widowed people 
to make more use of health services, not because of the death of the spouse, but because 
they have a higher chance of being ill, just as their partner was. We accounted for these 
 
Mean monthly HCE (€) Difference 
Before death 
of the spouse 
After death 
of the spouse  
€ % p 
      
Totala 486 757 271 56 <.001 
      
Medical carea 379 519 140 30 <.001 
General practicea 18 22 4 23 <.001 
Hospitalb 196 306 110 56 <.001 
Pharmacya 78 84 6 8 .219 
Otherb,c 87 106 20 23 .288 
      
Long-term careb 107 238 131 157 <.001 
Home careb 55 111 56 103 <.001 
Counsellingb 12 27 15 120 .017 
Care homeb 11 24 14 132 .051 
Nursing homeb 16 43 27 163 .057 
Otherb,d 13 32 19 144 .013 
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endogenous factors to the best of our ability by standardizing for socio-demographic 
factors. 
Bereavement is also related to health risks, and could therefore induce higher 
health care expenditure.24,25 The point estimates portrayed in figures 2 and 3 suggest 
that bereavement plays a minor role in the association between widowhood and health 
care expenditure as there is no peak in expenditure in the months after the death of the 
spouse. Also, the increase in health care expenditure after the death of the spouse is five 
times higher in the long-term care sector than the medical care sector. This suggests 
that expenditure levels predominantly rise because there is a higher need for formal 
care after the loss of an informal care-giver, rather than a higher need for medical treat-
ment related to the health impact of bereavement, marriage selection or a shared envi-
ronment.  
Other studies take the effects of marriage selection, a shared environment, and 
bereavement into account by directly measuring the ‘substitution’ effect of informal 
care reception on health care utilization.26-31 These authors show that informal care has 
a preventive role, or in other words, that care provided by spouses, family members, 
and friends substitutes for formal health care. It is plausible that this substitution effect 
is a major contributing factor to the association we found between widowhood and 
health care expenditure. Because our data are retrieved from a follow-up study, we can 
separate the direct effects of bereavement, and by standardizing for age and socio-eco-
nomic status we have at least partly avoided the interference of marriage selection and 
a shared environment.  
 
The economic value of informal care and prevention programs 
Our findings are particularly useful for economists studying the impact of human be-
haviour or the costs and benefits of prevention programs. Because informal care is not 
financially compensated, it is usually not taken into account in economic analyses. In 
literature, it remains unclear what the best method is to express informal care in eco-
nomic terms.32 The economic value of formal care use prevention can be used as a 
method to value the dynamics of informal care as an alternative to, for example, the 
‘proxy-good method,’33 or the ‘willingness-to-pay method.’34 Research on the economic 
burden of smoking is an example of a field in which the economic valuation of informal 
care is lacking. Some authors have concluded that smoking benefits the economy, be-
cause smokers usually don’t reach higher, more expensive ages.35-37 However, these 
studies focus only on individual health care expenditure during the life course and fail 
to take into account that people outliving their smoking partners have a higher chance 
of requiring formal care. A part of the higher average levels of life course health care 




expenditure of non-smokers is thus caused by smoking partners who cause second-
hand smoke and die younger. Consequently, when the effect of second-hand smoke and 
informal care are taken into account in these analyses, the real costs of smoking are 
higher than currently reported. 
This study can also benefit policy-makers and physicians. For example, results 
show that health care expenditure of older people is not only higher after the death of 
the spouse, but also in the months before widowhood. Emotional stress and a higher 
burden of informal care could be an underlying dynamic. It is also possible that some 
subjects postponed the use of health care services for themselves until intensive care 
for their dying spouse was no longer required. Intervention programmes including in-
formation, support, therapy, and respite care for older people providing intensive care 
for their spouses could have financial merit besides any potential beneficial effects on 
well-being.38 Similarly, widows and widowers may benefit from an expanded role for 
general practitioners. Older people can suffer from confusion, apathy, dependency, and 
depression after the death of their spouse. A pro-active general practitioner can assist 
and support those recently widowed to improve their independence and well-being, 
also diminishing the need for medical treatment or care in the long run.39 Our results 
suggest there is room for such interventions, as the level of expenditure in the sector of 
general practice increases just slightly (€4 per month) after the death of the spouse.  
An important strength of our paper is that individual characteristics and ex-
penditure levels were collected within a large study population over a relatively long 
time period (July 2007 through 2010). However, we could only collect data on marital 
status and some widows and widowers will have started a new relationship outside the 
bonds of marriage. Also, information on the causes of death of the spouse, or the actual 
reception of informal care before widowhood was missing. Additionally, the effect of 
the death of the spouse on health care expenditure is likely mediated by the presence 
of children, as well as other family members or friends. On the other hand, not all wid-
owed subjects from our study received informal care prior to widowhood, showing that 
informal care provided in spousal relations is economically more valuable than the ex-
tra 239 euros per month that widowed people cost. Hence, we want to emphasize that 
we have measured the effect of having a spouse on health care expenditure and not the 
effect of informal care per se. 
To our knowledge, we are the first to perform an in depth investigation into the 
effect of the loss of a spouse on health care expenditure through time. Our results are in 
line with previous papers on the utilization of health care by widowed people. Our re-
search not only points out the value of informal care to society in economic terms, but 
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also provides further basis to develop interventions for the support of widows and wid-
owers. This way, future financial strains on the health care system can be avoided, and, 
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Supplementary figure 1: Flowchart of data collection.
 
Analysis 2: The effects of the death of  
the spouse on health care expenditure 
Analysis 1: The effects of socio-demographic 
 determinants on health care expenditure  
n = 65,712 
Identifying variables missing (n=953) 
Unknown forms of intramural long-
term care (n = 3,162) 
No consistency in medical care ex-
penditure (n = 26) 
Data on clients unknown at CBS 
(n = 47) 
Received multiple, overlapping long-
term care activities (n = 29) 
Clients who did not lose a spouse in 
2004-2011 (n = 55,008)  
All subjects from health insur-
ance company ZZ of whom 
both medical and long-term 
expenditure is known, born 
before 1-1-1946.  
n = 64,759 
n = 61,495 
n = 61,524 
n = 61,597 
n = 61,571 
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Background: The health care costs of population ageing are for an important part at-
tributable to higher mortality rates in combination with high costs of dying. This paper 
answers three questions that remain unanswered regarding the costs of dying: (1) con-
tributions of different health services to the costs of dying; (2) variation in the costs of 
dying; and (3) the influence of preceding health care expenses on the costs of dying.  
Methods: We retrieved data on 61,495 Dutch subjects aged 65 and older from July 2007 
through 2010 from a regional health care insurer. We included all deceased subjects of 
whom health care expenses were known for 26 months prior to death (n=2,833). Costs 
of dying were defined as health care expenses made in the last six months before death. 
Lorenz curves, generalized linear models and a two-part model were used for our anal-
yses.  
Results: The average costs of dying are €25,919. Medical care contributes to 57% of 
this total, and long-term care 43%. The costs of dying mainly relate to hospital care 
(40%). In the costs of dying, 75% is attributable to the costliest half of the population. 
For medical care, this distribution figure is 86%, and for long-term care 92%. Age and 
preceding expenses are significant determinants of this variation in the costs of dying. 
Overall, higher preceding health care expenses are associated with higher costs of dy-
ing, indicating that the costs of dying are higher for those with a longer patient history.  
Conclusions: There is not a large variation in the costs of dying, but there are large 
differences in the nature of these costs. Before death, the oldest old utilize more long-
term care while their younger counterparts visit hospitals more often. To curb the 











Health care expenses in many ageing populations continue to rise.1 However, ageing 
itself is only a minor determinant of this rise. First, because the growing share of older 
people in many nations has only a marginal influence on the rise in health care ex-
penses. Other factors – such as technological innovations – are found to be more im-
portant drivers of this rise.2,3 Second, many studies show that, on an individual level, 
health care expenses increase manifold in the time close to death and overshadow rises 
in expenses due to advanced age alone.4-7 Since health care expenses made at the end 
of life play a relatively large role in total health care cost levels, it is important to under-
stand what factors influence these expenses. Many studies exist that discern the influ-
ence of different factors on health care expenses before death, but there are still gaps in 
literature that prevent social scientists, clinicians and policy-makers to gain a full un-
derstanding.  
There is little insight into how the different health service types are affected by 
impending death. With some exceptions,8-12 all studies investigating the effect of prox-
imity to death on health care expenses focus on one sector or service type – often the 
hospital. De Meijer (2011) and Wong et al. (2011) have also focused on Dutch data, and 
analysed the costs of dying in long-term care and hospital care respectively.13,14 How-
ever, to our knowledge we the first to study the costs of dying for all health service types 
– including general practice, pharmacy, counselling, and hospices – using subjects from 
a single database.  
Second, although authors have shown clear evidence that certain factors raise or 
lower the level of health care expenses before death, it remains unknown whether there 
are large differences in the costs of dying between individuals and what factors have 
the largest influence on this variation. Studies show that the expenses before death de-
crease with age in the medical care sector,15-18 but increase in the long-term care sec-
tor.11 Also, it has been found that women have higher levels of health care expenses in 
general and close to death,11 but is unclear whether this a gender effect or a widowhood 
effect. Women have lower mortality rates than men, increasing their chance of being 
widowed, and it has also been found that subjects without a partner have higher levels 
of health care utilization and expenditure, also prior to death.19-22 Besides socio-demo-
graphic characteristics, cause of death seems to play a role in the level of health care 
costs before death. It has been found that expenses before death are highest for cancer, 
and lowest for cardiovascular diseases, although other causes of death have no signifi-
cant impact.23,24  




Third, it is unknown whether individuals with a longer history of illness or disability 
have higher or lower costs of dying. It has been shown that health care expenses start 
rising as early as 31 months before death,25 but it is unclear whether higher expenses 
at this time are associated with relatively higher or lower expense levels just before 
death. It is possible that death comes more unexpected for individuals who had an over-
all lower morbidity level, leading to more intensive and aggressive treatment at the end 
of life. Earlier health care expenditure levels form a decent indicator an individual’s his-
tory of morbidity. It has been found that whites and females have higher health care 
expenses in general than others, but lower levels close to death.18,26 This stands in con-
trast to the finding that higher expenses are incurred in the last year of life for people 
with a higher cardiovascular risk profile earlier in life.27 To summarize, it remains un-
clear how large the variation is in the costs of dying, and what socio-demographic fac-
tors are contributors to variation. 
Therefore, we performed an analysis of the variation in the costs of dying, and 
the factors that have a possible influence on this variation. First, we calculate the costs 
of dying in the study population, and we further divide expenses by health service type, 
to see which types are affected most by impending death. Second, we portray the vari-
ation in the costs of dying in a Lorenz curve. Hereafter, we provide an oversight of what 
factors influence a potentially skewed distribution. Thirdly, we include preceding 





With the aim to perform multiple studies on the association between the life situation 
of older people and their health care costs, the Leiden Health care Costs in Old Age 
(LHCOA) study was started in 2011. For this study, data on health care costs for 61,495 
people aged 65 and older in a period of 42 months were retrieved from a regional Dutch 
health insurer (Zorg & Zekerheid) and matched with data on socio-economic character-
istics from the Central Bureau of Statistics (CBS). Data were collected in the following 
steps: 
1. After consulting the IRB (legal department) of the regional health insurer, data on 
medical care expenditure were retrieved from the health insurer’s management in-
formation system. Data were collected for the period July 2007 through 2010 for all 
persons who lived in the regions where the health care insurer acted as the long-
term care office, and who reached the age of 65 before 2011. Addresses were linked 




with data on socio-economic status by postal code, provided by the Netherlands In-
stitute for Social Research. 
2. Collecting data on medical care expenditure by service type proved to be highly time 
consuming. These data were only retrieved for a subpopulation, randomized for so-
cio-economic status. Eight service types were identified: general practice, hospital, 
pharmacy, allied health care, psychology, instrumental aids, dental care, and other 
medical care. 
3. In accordance with the IRB of the health insurer, data on long-term care utilization 
were collected from the EMEA Care Registration system (ECR), an information sys-
tem which offers an oversight of all the coded messages that are sent between or-
ganizations active within the confounds of the EMEA. ECR messages designating the 
start and end of long-term care provision were linked with national average fees per 
volume unit, provided by the Health Insurance Board. The received volume of extra-
mural treatment were unknown, and no costs could be calculated for this service 
type. 
4. After consulting the IRB of the CBS a single transfer of data from the health insurer 
to the CBS was done over a secure line. CBS staff merged the data using citizen ser-
vice numbers and dismissed any personal data afterwards. The authors could then 
only access the de-identified data in a secured room of the CBS. The authors had no 
access to identifying information. Any output destined for publication was first scru-
tinized by the IRB of the CBS, so no output could be traced back to individuals. No 
data is publicly available. Data collection and analysis was in full accordance with 
privacy legislation and protocol. Socio-demographic variables collected at the CBS 
were: age, gender, marital status, and time of death.  
5. After these steps, the total study population comprises 61,495 subjects. Medical care 
costs by service type are known for 18,995 subjects. 
 
The total study population of the LHCOA study (n=61,495) was split up into two groups: 
subjects who died in the studied time period (n=9,202), and those that survived 
(n=52,293). We defined the costs of dying as the expenses in the last six months before 
death. We selected average expenses made two years prior to death to represent pre-
ceding health care expenses. To retrieve a more robust estimate of these preceding 
health care expenses, and to be better able to compare these expenses with the costs of 
dying, we used the 26th through 21st month prior to death. From the group of subjects 
who died before 2012, we then selected only those for which health care expenses were 
known from the 26th month before death to the month of death (deceased population, 
n=2,844). Medical care expenses per service type were known for 926 subjects. In the 




population of surviving subjects, we selected those for whom health care expenses were 
known in 26 consecutive months in the same calendar time period as the deceased 
group. This group is referred to as the non-deceased group (n=42,204). In the non-de-
ceased group, medical care expenses per service type were known for 12,996 subjects.  
 
Statistical analysis 
Regression models were used to test the association between different determinants 
and health care expenditure. As the distribution of health care expenditure is skewed 
and the association with the determinants is subject to heteroskedasticity, we used a 
generalized linear model GLM with gamma distribution and a log link.28 Many zero out-
comes were encountered in the data on long-term care expenditure (25%), implying 
that an analysis with a two-part model is needed for this sector.29 The number of zero 
outcomes were relatively small for the medical care sector (2.5%) and for total health 
care ( <.01%). In our two-part model, we chose to use a probit model for the first part, 
and a GLM with gamma distribution and a log link for the second part.14 
First, to retrieve insight into the costs of dying we calculated mean figures on 
health care expenses from the deceased group for every month before death (up to the 
26th month before death). For comparison, the average monthly cost levels of the non-
deceased group were calculated, whereby the socio-demographic characteristics and 
calendar month were standardized on the means of the determinants in the deceased 
group. Second, the expenses in the last six months before death were calculated for dif-
ferent health service types. For each service type, the expenses in the last six months 
before death were compared with the expenses over a similar time period two years 
before death (26th through 21st month). Third, a Lorenz curve was made to portray the 
variation in the costs of dying. Specifically, the curve shows how the expenses in the last 
six months before death are distributed throughout the population. Fourth, we investi-
gated if socio-demographic characteristics, calendar time and preceding expenses could 
be associated with lower or higher levels in the costs of dying. A time variable (calendar 
month) was used because health care expenses change over time, mainly due to infla-
tion and health care reforms. To test whether the association between the costs of dying 
and preceding expenses was sensitive to the choice of the time period used to define 
preceding expenses, we also ran analyses in which preceding expenses were defined 










Table 1 shows the population characteristics of the deceased and non-deceased group. 
Age was divided into two groups based on the median of the deceased group. Socio-
economic status was classified on the basis of the median of the Dutch population. 
 
Health care expenses before death 
The left panel in figure 1 shows the trajectory of health care expenses before death. For 
comparative purposes the right panel of figure 1 shows the monthly expenses of the 
non-deceased. Health care expenses are higher in the deceased, at least up to 26 months 
prior to death. With €955, the level of monthly expenses in the 26th month before death 
is ±2 times the average monthly level of the non-deceased group. Spending rises steeply 
around six months before death. With €9,387 the relative difference increases to ±12.4 
in the last month before death.  
 






     
Gender     
Men 1,349 (47%) 20,537 (39%) 
Women 1,497 (53%) 31,756 (61%) 
     
Age     
< 75  836 (29%) 25,090 (85%) 
75-85 1,309 (46%) 14,419 (34%) 
≥ 85 699 (25%) 2,695 (6%) 
     
Marital status     
Married 1,148 (40%) 23,839 (56%) 
Widowed 1,331 (47%) 12,279 (29%) 
Divorced 179 (6%) 3,836 (9%) 
Never married 186 (7%) 2,250 (5%) 
     
Socio-economic status (SES)b     
Lower 724 (25%) 9,591 (23%) 
Higher 2,120 (75%) 32,613 (77%) 
     
a Figures are from the first month of follow-up. 
b The demarcation between lower and higher SES group is based on the national 
average (=6.10). 




Figure 1. Patterns in monthly costs of the deceased and non-deceased. Figures depict health care 
expenses, split up in medical care expenses and long-term care expenses, in the last 26 months 
before death for the deceased group (left panel) and in 26 months in the same time period for the 
non-deceased population (right panel). Expenses of the non-deceased are standardized on the 
mean socio-demographic characteristics of the deceased population for every month. Note the 
differences in the y-axes.  
 
Medical care expenses have a trajectory similar to that of total health care expenses. 
From the 26th to the last month before death, expenses rise from €525 to €6,315. The 
level of monthly medical care expenses of the deceased relative to the non-deceased 
group increases from 1.5 to 14.6. Long-term care expenses rise more gradual from the 
26th to the last month before death (from €430 to €3,072), although expenses double 
in the last 3 months of life. For long-term care, the ratio of monthly expenses of the 
deceased to the non-deceased increases from 3.8 to 8.7. 
Notable from figure 1 is that average long-term care expenditure in the non-de-
ceased group rises from €101 to €304 in 26 months time. Investigation of the data re-
veals that in this time period the long-term care utilization rate of the non-deceased 
increases with 86% (from 5.8% to 10.8%). Average fees per volume in long-term care 
increase with 9%, and the average care weight rises with 44%. These changes explain 
97% of the threefold rise in long-term care expenditure, and are partly related to the 
ageing of the non-deceased population in these 26 months (mean age rises from 80.1 to 
82.2 years).  
In table 2 the expenses in the last six months before death of a random subgroup 
(n=926) are split up in different service types. Mean expenditure in the 26th through 
21st month before death in this subgroup is €7,249. With €25,919, average expenditure 




in the last six months before death is 3.6 times as high. Hospitals, home care and nursing 
homes make up the highest shares in the expenses in the last six months before death, 
totalling €16,945 (65%). Hospital expenses in the last six months before death increase 
from €2,223 to €10,449. Consequently, the share of hospital expenses increases from 
31% to 40%. Expenses for home care increase from €1,524 to €3,542 (from 21% to 
14%), and expenses for nursing home care increase from €350 to €2,954 (from 5% to 
11%). In the last six months before death, cost shares are lowest for care from general 
practitioners and hospices (3.3% and 1.3% respectively). 
 
Table 2. Preceding health care expenses and the costs of dying by service type.  
Service type 
Preceding health care 
expenses,a in € (%) 
Costs of dying,b 
in € (%) 
     
Health care 7,249 (100%)  25,919 (100%) 
     
Medical care  4,240 (58.5%)   14,793  (57.1%) 
General practice   139 (1.9%) 851 (3.3%) 
Hospital   2,233 (30.8%)  10,449 (40.3%) 
Pharmacy 905 (12.5%) 1,564 (6.0%) 
Otherc   961 (13.3%) 1,931 (7.5%) 
     
Long-term care 3,009 (41.5%) 11,126 (42.9%) 
Home care 1,524 (21.0%) 3,542 (13.7%) 
Counselling & day-time activities 447 (6.2%) 1,593 (6.1%) 
Care home 454 (6.3%) 1,460 (5.6%) 
Nursing home 350 (4.8%) 2,954 (11.4%) 
Hospice 0 (0.0%) 349 (1.3%) 
Otherd 234 (3.2%) 1,227 (4.7%) 
     
Means are of all clients in the deceased population of whom expenses by medical service type are 
known (n=926, see methods section). Therefore, total mean costs are slightly different from the 
whole sample of 2,844 deceased subjects due to sample variation. 
a Preceding health care expenses are made in the 26th through 21st month before death. 
b The costs of dying are the expenses made in the last six months before death. 
c Physiotherapy, psychotherapy, acute mental care, dental care, instrumental aids, etc. 
d Long-term rehabilitation, care for the handicapped and mentally ill. 
 
Variation in the expenses in the last six months before death 
The Lorenz curves in figure 2 shows the distribution of expenses in the last six months 
before death in the population of deceased subjects (n=2,844). The share of these ex-
penses is set against the share of the population. Panel a shows that the 50% of the 
population with the highest expenses in the last six months before death contributes to 
75% of the total expenses prior to death. Concerning medical care, the more expensive 




half represents 86% of the total medical care expenses prior to death (panel b). The 
distribution figure is 92% for long-term care (panel c). 
 
Figure 2. Variation in the cost of dying. The popula-
tion distribution of the costs of dying (expenses in the 
last six months before death) in 2,844 individuals is 
shown for total health care (panel a), and split up in 
medical care (b) and long-term care (c). 




Table 3 shows if and how socio-demographic characteristics, calendar time and preced-
ing health care expenses (expenses in the 26th through 21st month before death) influ-
ence the expenses in the last six months before death. The average health care expenses 
in the last six months before death are €25,790. Age is a significant determinant of these 
expenses. For every year gained, expenses in the last six months of life decrease with 
€257, which equals 1% of the average total (p<.001). The mean difference in health care 
expenses in the last six months of life between a 65 and 85 year old subject is then 
€5,140, which equals 20% of the average. Calendar time is also a significant determi-
nant: health care expenses in the last six months of life increase with €185 every calen-
dar month (+0.7%; p=.014).  
Mean medical care expenditure in the last six months before death is €14,493. 
Medical care expenses in the last six months before death decrease with €479 for every 
year the age at death increases (−3%; p<.001). The mean difference in medical care ex-
penses in the last six months before death between a 65 and 85 year old subject is there-
fore €9,580 (−66%). Subjects that were never married have significant lower medical 
care expenses in the six months before death with €3,287 (−23%; p=.010). Mean long-
term care expenditure in the last six months before death is €11,298. Expenses in the 
last six months before death increase with €227 per year in this sector (+2%; p<.001). 
Consequently, this is a €4,540 rise from the ages 65 to 85 (+40%). 
Gender and marital status also play a significant role in long-term care expendi-
ture in the last six months before death. On average, women make €1,724 more long-
term care expenses in the last six months before death than men (+16%; p<.001). Ex-
penses by subjects who never had a spouse are €4,376 higher than expenses by married 
subjects (+39%; p=.001). Calendar time is also a significant determinant of long-term 
care expenses in the last six months before death (+€89; +0.5%; p=.048).  
Table 3 also shows that preceding health care expenses are significantly associ-
ated with health care expenses in the last six months before death. For every additional 
€1,000 spent on health care in the 26th through 21st month before death, health care 
expenses in the last six months before death rise with €274 (p<.001). Higher expenses 
in the medical care sector in the 26th through 21st month before death are associated 
with higher medical care expenses in the last six months before death (+€182; p<.001). 
If preceding expenses in the long-term care sector increase with €1,000, long-term care 
expenses in the last six months before death rise with €759 (p<.001), but medical care 
expenses lower with €434 (p<.001). Using other time periods to indicate preceding ex-
penses (29th through 24th month; 24th to 19th month) yields similar results. 
 
  

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The influence of age on expenses in the last six months before death and on average 
costs of the non-deceased are portrayed in figure 3. Panels on the left side show these 
expenses of different health services. Apparent from these panels is that expenses in 
the last six months before death rise with age for intramural long-term care (care 
homes, nursing homes, hospices, rehabilitation centres, and institutions for the handi-
capped). In contrast, expenses in the last six months before death for hospital, non-
hospital and extramural long-term care lower with age. For the non-deceased group, 
medical care expenses remain rather constant with age. However, long-term care ex-
penses increase rapidly with age: from a six months average of €475 for subjects aged 
65 to 75 to €3,216 for subjects 85 years and older. 
The influence of medical and long-term care expenses in the 26th through 21st 
month before death on expenses in both sectors in the last six months before death is 
portrayed in figure 4. Here, expenses in the 26th through 21st month before death in the 
medical care sector (left panel) and the long-term care sector (right panel) are divided 
into tertiles. The standardized expenses in the last six months before death in both sec-
tors are given for each tertile with a 95% confidence interval. Made visible is that med-
ical and long-term care expenses in the last six months before death increase when ex-
penses in the 26th through 21st month before death increase in the medical care sector 
(left panel). Long-term care expenditure in the 26th through 21st month before death is 
also associated with higher long-term care expenses in the last six months before death, 




There is not a large variation in the costs of dying of older people, but there are large 
differences in the nature of these costs. Mainly, the sum of expenses in the medical and 
long-term care sector is rather equally distributed, but there is a higher variation when 
the two sectors are taken separately. Main determinants of variation are age and pre-
ceding health care expenses. The costs of dying in medical care and extramural long-
term care decrease with age, while the costs of dying in intramural long-term care in-
crease with age. This implies that the younger share of older subjects spends more time 
at home or in the hospital before death, and the older share of subjects have a higher 
chance of receiving intramural care before death. The positive association between the 
costs of dying and preceding health care expenses imply that patients with more ex-
penses at the end of life had a longer history of illness or disability. 
 




Figure 3. Age and health care expenses. In the left panels, the costs of dying (defined as the ex-
penses in the last six months before death) are shown for different service types per age group. 
In the right panels, average health care expenses for six months of the non-deceased are shown. 
Expenses in both panels are standardized for socio-demographic characteristics and calendar 
time. Results are for 2,844 individuals in the deceased group and 42,204 in the non-deceased 
group. Note that the figures on hospital and non-hospital care are available for 926 and 12,996 
subjects respectively (see methods section). Also note the differences in the y-axes. 





Figure 4. Preceding health care expenses and the costs of dying. The costs of dying are shown for 
medical care and long-term care (n=2,844), and are defined as the expenses in the last six months 
before death. Preceding medical and long-term care expenses are defined as the expenses in the 
26th through 21st month before death. Costs of dying are standardized for socio-demographic 
characteristics and calendar time. 
 
 
The finding that medical care expenses decrease with age for both decedents and sur-
vivors is consistent with the earlier findings that, with age, less costly illnesses become 
more common and treatment intensity decreases.30-32 Another plausible explanation 
for decreasing medical care expenses with age is a substitution effect from long-term 
care. The risk of care home and nursing home admission increases with age, and basic 
forms of medical care provided in these institutions fall under the category long-term 
care through Dutch legislation. In other words, higher expenses in intramural long-term 
care automatically implies lower expenditure on medical care. 
Where medical care expenses show a boom in the last two to three months be-
fore death, long-term care expenses grow more slowly before death. This longer run-
up is in accordance with literature.8,10,11,21 Expenses for hospital care, home care and 
nursing home make up two-thirds of the total costs of dying. Although spending on gen-
eral practice and hospice care increase manifold with impending death, their shares in 
the total level remain very small (together 4.6%). The increase of expenses on general 
practitioners will likely be caused in part by their role in end-of-life decision-making in 
the Netherlands.33 Results further show that higher preceding expenses are associated 
with higher expenses prior to death. It is plausible that preceding medical care expenses 
reveal previous or chronic health problems, which induce more expenses later in life 




due to exacerbation of these illnesses or due to the occurrence of additional complica-
tions.23 A similar dynamic may exist in the long-term care sector. Preceding expenses in 
this sector form a crude indicator for disability and/or frailty. It is therefore plausible 
that elderly with a history of disability and/or frailty have higher costs of dying in the 
long-term care sector.13,34 
It is not unexpected that age is an important determinant for the costs of dying 
in long-term care, as a major part of the long-term care in the Netherlands is spent on 
elderly care for the oldest old. A plausible reason why older people without a partner 
have higher costs of dying is that informal care by partners substitutes for formal 
care.20,22 Only age and preceding health care expenses seem to play a role in the varia-
tion in the medical care sector. In literature, the prevalence of disability, chronic ill-
nesses and other health problems is reported to be higher in lower socio-economic 
groups than higher ones.35 However, we could not find a significant influence of socio-
economic status on the costs of dying in both sectors. It is possible that the socio-eco-
nomic status indicator was too crude for regression purposes, as socio-economic status 
was not individually defined, but based on the average education level, income and cap-
ital of the postal code of each subject. 
The relatively important role of calendar time on the costs of dying could for the 
most be explained by inflation and policy changes. The data shows that the effect of 
calendar time is most prevalent in long-term care. A similar trend is visible on the na-
tional level: the total level of long-term care expenditure has risen from 21.7 billion eu-
ros to 24.1 billion euros in the Netherlands between 2008 and 2010 (an 11% rise). It is 
also possible that, in some cases, long-term care utilization was not recorded properly 
before July 2007. Therefore, a few individuals may have used long-term care in the be-
ginning of the study period, although this was not observed until a new coded message 
was issued in the EMEA Care Registration system. The threefold rise in long-term care 
expenditure of the non-deceased group in 26 months seen in figure 1 was explained by 
an increasing number of subject using long-term care, a change in care weight, and a 
rise in compensation per volume unit. These changes are partly caused by a two years 
increase in age (from 80 to 82 years) in the non-deceased group during these 26 
months. 
 The goal of this study is to answer the question whether there are large differ-
ences in the costs of dying between individuals. We are the first to provide a compre-
hensive oversight of the factors causing variation, including preceding medical and 
long-term care expenses. Potential causes of variation other than socio-demographic 
factors and preceding expenses were not taken into account. Cause of death could be an 
additional explanatory variable concerning variation in the costs of dying. Also, levels 




of social support through family-members and friends could influence long-term care 
expenses in general and late in life.36,37 A plausible reason why deceased subjects who 
were never married make considerably more expenses in the last six months of life, is 
that many of them will not have children to provide informal care. However, the higher 
share of (mentally) disabled persons in the never married group will also have a pro-
found impact on long-term care expenses.  
There is a debate on the usefulness of time to death as a determinant of health 
care expenditure. A main objection is that proximity to death is only observable in ret-
rospect, making forecasts on a micro-level impossible. On a macro-level, time to death 
is proposed to be useful only as a proxy for more appropriate determinants when these 
are not available, such as severe illness, disability, or frailty.13 However, implications of 
our findings are useful for health policy-makers and clinicians involved in end-of-life 
care. Policy-makers need to consider the specific implications of population ageing on 
the health care system. Population ageing refers to three key points: (1) a rising life 
expectancy, (2) higher mortality rates, and (3) an increasing share of frail and disabled 
people. Higher mortality rates may increase health care expenditure, as costs rise 
steeply in the last months before death. However, the costs of dying decrease with age. 
This implies that rising life expectancy will dampen the cost-inducing effect of higher 
mortality rates. In the non-deceased group, medical care costs stay rather stable with 
age. Since per capita costs in intramural long-term care in the deceased and non-de-
ceased rise steeply with age, it is possible that the demand for institutional long-term 
care will rise when both the number of frail elderly as well as life expectancy is increas-
ing. However, it is also possible that demand will only be postponed, as healthy life ex-
pectancy is also increasing. 
The share of hospital services is considerable in the costs of dying. It has been 
found, however, that higher costs of dying in the hospital are associated with a lower 
quality of death.38 Consequently, further investigation is needed to find out if there is 
room for decreasing the costs of dying without sacrificing quality of life in the months 
before death. Results from a small number of studies suggest that end-of-life conversa-
tions and care-planning for older terminal patients can safely decrease expenditure lev-
els in hospitals and nursing homes.38-40 It is also possible that the marginal role of care 
from general practitioners and hospices can be expanded in the last months of life, but 
more research is needed on patient perspectives and (variation in) expenditure prior 
to death. Knowledge about these subjects will increase the understanding of ever in-
creasing health care expenses and, more importantly, might contribute to the improve-
ment of the quality of life close to death. 
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In this thesis, we investigated the determinants of mortality, health care expenditure 
(HCE), and the ‘costs of dying’ in the older population to gain a better understanding of 
how an ageing population affects HCE. We separated the determinants into two catego-
ries: (1) determinants that apply to the country as a whole (the macro-level); and (2) 
determinants that are relevant for individuals (micro-level). Chapters 2 through 4 re-
late to the macro-level: the national economy, seasonal changes, and national policy. 
Micro-level determinants – partner status, costs of dying, and individual tailoring of 
health care – are assessed in chapters 5 through 7. 
 
Macroeconomic cycles and old age mortality 
In chapter 2 we analyse the association between gross domestic product and mortality 
in all citizens of middle and old age in 19 developed countries between 1950 and 2008. 
We find that mortality rates in both age groups increase during upward cycles in the 
economy, and decrease during downward cycles. The effect is stronger in men than in 
women. Similar results are found in a broad range of previously published studies per-
formed for many different countries.1-11 However, our analyses differs from these stud-
ies in several ways. First, we use cycles in gross domestic product rather short-term 
deviations in unemployment around cycles. We reason that cycles potentially capture 
more fundamental and long-lasting shifts in the economic environment of all citizens, 
while the annual deviations relate to sudden changes in the employment status of a rel-
atively small part of the population. 
Second, we specifically set out to compare a group of middle aged citizens with a 
group of older citizens. If changes in the economy affect people’s health through 
changes in employment status or job stress – as is hypothesized by others12 – one would 
expect to find a smaller association for the older, retired population. However, since the 
association is at least as strong for the older age group, this hypothesis needs to be re-
vised or amended. We reason that older people might also show lifestyle improvements 
during downward cycles in the economy, and may receive more informal care from 
their children, who have a higher chance of becoming unemployed are receiving less 











Seasonal changes  
In chapter 3 we assess whether the mortality risk, medical care expenses (MCE), and 
institutionalization risk of older people changes with the seasons. It has been shown 
that there is seasonal variation in mortality,13-21 but seasonal variation in MCE and in-
stitutionalization risk has not been studied. As MCE rise exponentially before death, it 
is plausible that MCE shows seasonal variation because of seasonal variation in mortal-
ity. We therefore analysed whether there was seasonal variation in MCE separately 
from the possibly mediating effect of mortality, by dividing the study population in a 
deceased and survivor group. 
We find that mortality rates and MCE of older people differ significantly between 
the seasons, and are higher in the winter and autumn compared to spring and summer. 
Institutionalization rates are significantly higher in the winter, but the other seasons 
show no significant impact. The changes in mortality risk and MCE show that older peo-
ple’s health is affected by the seasons. Results from previous studies suggest that tem-
perature and flu prevalence could play a pivotal role in these seasonal changes. How-
ever, we find that the mortality rates of institutionalized elderly also change with the 
seasons, which implies that season-dependent outside temperature cannot solely ex-
plain seasonal variations found in this study. 
 
Gatekeeping 
After analysing the impact of the economic and seasonal environment on older people’s 
health and related expenses, we focused on the possible influence of the health care 
system in chapter 4. In this chapter, we analyse whether utilization of care from gen-
eral practitioners affects expenses for other health care services later in time. First, we 
hypothesize that GP expenditure is inversely associated with expenses for other health 
care services later in time in a population of older people, because GPs prevent overuti-
lization of specialist care through watchful waiting, and the provision of basic treat-
ments at lower costs. Adjusting for morbidity is crucial. However, because we could not 
acquire data on specific diagnosis codes of individuals due to privacy concerns, we try 
to adjust for morbidity to the best of our ability by using different determinants in our 
statistical analysis, viz. baseline health care consumption, socio-demographic charac-
teristics, mortality and time variables. 
The analysis shows that GP expenditure is positively correlated with expenses 
for other health care services later in time: for every €10 spent on GPs, expenses for 
other health care services later in time increase with €74 (p<.001). The positive asso-
ciation can be explained by three dynamics: (1) expenses for GPs are automatically as-
sociated with expenses for other health care services because patients often receive or 




even require a referral from the GP before receiving specialist health care; (2) GPs could 
increase the overall level of HCE by improper diagnoses or unnecessary referrals; (3) 
our statistical methods did not adequately account for the likelihood that patients who 
have more health problems visit GPs and other health care providers more frequently. 
 
A transitional care programme 
Similar to the latter chapter, chapter 5 also focused on the impact a health system can 
have on the HCE of older people. In contrast to chapter 4 however, we focus here on an 
implementable small-scale care programme directed at individually tailoring health 
care for older people with multi-morbidity, rather than on an existing national health 
care policy. The programme consists of four major components: (1) risk assessment of 
frail older people; (2) an integrated multidisciplinary care structure to improve the care 
pathway; (3) improved follow-up of care; and (4) optimization of transition of care. The 
cohort in the transitional care programme is compared to a cohort with non-participa-
tion from an earlier period in time. 
Pre/post evaluations show an improvement in outcomes for frail older hospital-
ised patients through co-creation of a transitional care programme: compared to the 
first cohort, patients in the second cohort suffered less adverse outcomes, while long-
term care expenditure except for rehabilitation remained the same. These results thus 
suggest that a transitional care programme, as described above, can improve the health 
of frail, older people. The first cohort was assessed in 2010 and 2011, while the second 
cohort was assessed in 2012 and 2013. Between these two time frames, other policy 
changes could have had a considerable effect on the outcomes as well.  
  
The loss of the spouse 
In chapter 6 we focus on an important determinant of an older individual’s HCE: part-
ner status. More specifically, here we aim to study HCE in the months before and after 
the loss of the spouse while adjusting for socio-demographic characteristics and calen-
dar time. Previous research shows that the loss of the spouse by an older person in-
creases the risk of nursing home admission,22-26 and has a detrimental effect on the 
health of the recently widowed.27-29 It would therefore be plausible that health care 
costs also rise after the death of the spouse. However, health care costs could also rise 
because, with the loss of the spouse, an older individual will have lost his or her most 
important informal caregiver, and will now need to acquire care from the formal care 
sector.  
We found that, on average, health care costs increases with €239 per month 
(+48%) after the death of the spouse. Overall, the rise sets in at the month someone 





becomes widowed and remains at this level for at least 3½ years. The rise in health care 
costs is highest for men (+59%) and the oldest old (+82%). The relative increase in 
long-term care expenditure after the loss of the spouse is five times higher in the long-
term care sector than in the medical care sector. For this reason, and also because there 
is no temporary peak after the death of the spouse, which would be consistent with a 
bereavement effect, it is plausible that this sudden but sustained rise in health care 
costs is – for a large part – attributable to the loss of an important informal caregiver.  
  
The costs of dying 
There is a large body of research on the association between proximity to death and 
HCE.30-41 However, in chapter 7 we focus on a question that remained unanswered in 
this research area: what is the variation in the ‘costs of dying’? Besides socio-demo-
graphic variables and calendar time, which we include in the analyses of previous chap-
ters, we also include preceding health care expenses in our analysis. We hypothesize 
that patients with a longer history of illness or disability would have lower costs of dy-
ing than those without such a history, because death might be more anticipated. 
We found that the variation in the costs of dying of older people is small, and that, 
in accordance with literature, the costs of dying become lower with increasing age. 
However, there are large differences in the nature of expenditure at the end of life: when 
the costs of dying are separated in medical and long-term care expenditure there is a 
large variation within each of the two sectors. This variation is mainly caused by age: 
costs of dying of the oldest old pertain mainly to long-term care expenditure, while the 
costs of dying of their younger counterparts pertain mainly to MCE. Main determinants 
of variation in the costs of dying are age and preceding health care expenses. The latter 





As was outlined in the introduction, the term population ageing refers to three dynam-
ics: (1) rising life expectancy; (2) a higher share of people of advanced age; and (3) in-
creased mortality rates. These three dynamics will be discussed here, incorporating the 
results of the former chapters. The limitations of the analyses reported in this thesis 
will be described thereafter. 
 
 




Rising life expectancy 
Life expectancy is continuously on the rise in developed countries.42-44 Whether a rising 
life expectancy will increase or dampen health care costs depends on the trajectory of 
healthy life expectancy. If the increase in healthy life expectancy will lag behind the in-
crease in life expectancy – or if healthy life expectancy will even decrease – the average 
number of life years spent in ill health per individual will increase, and, consequently, 
health care costs will rise. 
It was found that healthy life expectancy lagged behind life expectancy in 187 
countries between 1990 and 2010: worldwide, life expectancy at birth increased with 
4.7 for men and 5.1 for women, while healthy life expectancy increased with 4.2 for men 
and 4.5 for women.45 This implies that the gap between life expectancy and healthy life 
expectancy grows with ~0.03 per year; a small increase, of which the impact on HCE is 
unknown.  
In the Netherlands, both disability-free life expectancy and life expectancy in 
good self-reported health did not lag behind life expectancy between 1985 and 2010.46-
48 However, remarkably, life expectancy without chronic disease decreased in this time 
period. This does not imply that the health of individuals deteriorated, but this down-
turn can be, in part, explained by an earlier detection and treatment of chronic diseases 
due to advances in medical knowledge and technology. However, it has been estab-
lished that earlier detection and medical advances do not provide the full picture, and 
that the prevalence of chronic diseases – like diabetes and atrial fibrillation – has in-
creased in recent decades.49,50 This increasing prevalence can be traced back to changes 
in lifestyle, but also to an increasing share of older people (see next paragraph). All in 
all then, healthy life expectancy shows a marginal lag behind life expectancy, and an 
important part relates to changes in lifestyle, and not demographic changes.  
If we then shift the focus from healthy life expectancy to life expectancy, we can 
see that a rising life expectancy may even have a dampening effect on HCE. We found 
that the costs of dying in the medical care sector decreases with age, and that MCE un-
related to death remain rather stable with age. Although the costs of dying in the long-
term care sector do increase with age, the total costs of dying (medical and long-term 
care) still decrease with age. To summarize then, it is plausible that an increasing life 
expectancy will have the following consequences: (1) the average costs of dying in so-
ciety will decrease, (2) the level of MCE unrelated to death will remain rather stable, 
and (3) long-term care expenditure (LTCE) might also remain stable as, with an increas-
ing life expectancy, the onset of disability and frailty will be postponed – as opposed to 
the idea that people will live longer with disability and frailty. 
 





Higher share of older people 
Although MCE does not increase with age, LTCE does. Consequently, an increasing share 
of older people will predominantly affect LTCE, and will have no or little effect on MCE. 
However, fundamental changes in the long-term care sector in many countries could 
partly prevent such a rise in LTCE. In the Netherlands, the long-term care act is cur-
rently downsized: the responsibility of extramural long-term care is gradually trans-
ferred to municipalities through the Social Support Act, and their limited budgets will 
cause heavy cutbacks in extramural long-term care. Also, more strict inclusion criteria 
for intramural care will further decrease LTCE. 
Second, results from previous literature suggests there is a substitution effect 
between informal and formal care.51-56 When increasingly fewer elderly are eligible for 
long-term care, it is to be expected that informal care will become more prevalent in the 
future. Also, additional efforts by policy-makers to stimulate informal care may further 
reduce levels of LTCE. It would be wise for policy-makers to better promote and facili-
tate informal care in times of economic expansions, as it is possible that informal care 
attenuates during good economic times, and rekindles during economic downturns (see 
chapter 2). 
Third, we find that older people have a fivefold increase in LTCE when they lose 
their spouse, which further corroborates the substitution effect between formal and in-
formal care described above. As the life expectancy of men is rising faster than that of 
women, it is plausible that the number of widows will decrease in the future. This will 
then have a dampening effect on the average individual level of HCE, and especially 
LTCE.  
Fourth, a large share of older people – especially the oldest old – suffer from mul-
tiple chronic diseases. Multi-morbidity places a high burden on the health care system 
and expenses. However, initiatives such as the transitional care programme described 
in this thesis (chapter 5), can potentially improve the quality of life of older people. Sim-
ilar initiatives may provide more efficient means to improve the coordination and pro-
vision of care for patients suffering from multi-morbidity and frailty.  
 
Higher number of deaths 
Over the course of decades, even centuries, advances in economic welfare, nutrition, 
public health, and medicine have contributed to a reduction in mortality – and therefore 
an increase in life expectancy – in most regions in the world.57-59 In accordance with 
literature,32,37,41,60 we find that MCE at the end of life decrease with age at death – with 
approximately 3% per year (see chapter 6). Also in accordance with literature,38 we find 
that LTCE at the end of life increases. However, we are the first to find that total HCE 




(i.e., the sum of MCE and LTCE) decrease with age (~1% per year). This implies that an 
increase in life expectancy will lead to a decrease in the average costs of dying. In con-
clusion, as the total number of deaths will increase due to population ageing, the level 
of costs associated with the end of life will also increase. However, it is unclear how 
much a rising mean age at death will offset this trend. 
 
Strengths and weaknesses, implications for future research 
We had access to different extensive datasets to make the studies presented in this the-
sis possible, including data from Statistics Netherlands, a regional health care insurer, 
the Human Mortality Database, the Angus Maddison dataset on historical economic in-
dicators, and the Netherlands Institute for Social Research. We believe these rich da-
tasets provide the backbone of our results, and form a major strength of this thesis. 
Unfortunately, specific forms of useful data could not be collected. This was es-
pecially the case for chapter 4, where we analysed the association between baseline 
expenses for GPs and expenses for other health care services to clarify the impact GP 
gatekeeping could potentially have on HCE. Due to privacy concerns, we could not col-
lect or construct data that was crucial to adjust for confounding in the form of morbid-
ity. The statistical mechanisms we exercise could probably not adequately capture a 
good indicator for morbidity. We strongly advise researchers to establish a solid and 
specific indicator for morbidity for future research. Further research is necessary, as 
the GP could play a pivotal role in making the health care system more sturdy and effi-
cient in dealing with population ageing. 
In another example, data on seasonality reflected monthly estimates in a rela-
tively short period of time (3½ years). Ideally, daily estimates of disease incidence 
rates, mortality rates (by cause of death), MCE, and institutionalizations in combination 
with daily data on temperature, sunlight hours, atmospheric pressure, flu prevalence, 
and air pollution could have revealed much more information on the intricate and 
multi-faceted association between the seasons and health, HCE, and mortality. 
For future research on the association between the economic environment and 
old age mortality, we would encourage researchers to use macro- or observational data 
to further specify who suffers during economic changes, and why. Do the unemployed 
show more risky and violent behaviour, such as addiction, suicide and homicide? And 
do those who remain employed show an improvement in lifestyle? And last but not 
least, do those with less working hours during economic crises find more time to spend 
with their parents or other older relatives, possibly in the form of informal care?  
 
 







Population ageing affects health care expenditure through a myriad of dynamics which 
can be categorized in three major components: rising longevity, a higher share of older 
people, and increasing mortality rates in combination with high ‘costs of dying’. By dis-
entangling these dynamics, and relating the insights presented in this thesis on the de-
terminants of old age mortality, health care expenditure, and the costs of dying, we have 
shown that the effect of population ageing on health care expenditure may be curtailed 
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Veel landen staan op de drempel van een belangrijke demografische verschuiving. Deze 
verschuiving in leeftijdsopbouw wordt in Nederland vaak ‘vergrijzing’ genoemd. De 
term vergrijzing wordt vooral geassocieerd met een toename van het aantal ouderen, 
die zal leiden tot een hogere druk op de collectieve financiën, vooral door een hogere 
vraag naar medische en langdurige zorg. Uit economische studies blijkt echter dat de-
mografische verschuivingen een marginale invloed hebben op de stijgende zorguitga-
ven; in vergelijking hebben medische ontwikkelingen, een achteruitgang in de efficiën-
tie van arbeid en herstructurering van de zorg een veel grotere impact.1-3 
Om de implicaties van de genoemde demografische verschuiving in zijn geheel 
te begrijpen moeten drie separate ‘dynamieken’ van de vergrijzing onderkend worden: 
(1) een hogere levensverwachting; (2) een groeiend aandeel ouderen in de algehele po-
pulatie; (3) een hoger gemiddeld sterfterisico in de algehele populatie. In dit proef-
schrift richten we onze aandacht op verschillende factoren die deze dynamieken beïn-
vloeden, variërend van klimaatfactoren tot de individuele levensloop. 
Voor ons onderzoek hebben we gebruik kunnen maken van verschillende data-
bases. Door data van een zorgverzekeraar en het Sociaal Cultureel Planbureau te kop-
pelen aan data van het Centraal Bureau voor de Statistiek hebben we inzicht gekregen 
in de socio-demografische kenmerken en individuele zorgkosten van 61.495 ouderen 
in de regio van Leiden. Deze data zijn gebruikt voor hoofdstuk 3 t/m 7. Voor hoofdstuk 
2 hebben we gebruik gemaakt van publiekelijk beschikbare data van Angus Maddison 
(historische data van landelijke welvaartscijfers) en de Human Mortality Database (his-
torische data van landelijke sterftecijfers). 
 
Overzicht van het proefschrift 
 
Deel I van dit proefschrift bevat drie hoofdstukken (hoofdstuk 2 t/m 4) waarin enkele 
‘macro-niveau’ factoren worden behandeld die de sterftekans en zorguitgaven van ou-
deren kunnen beïnvloeden. In hoofdstuk 2 onderzoeken we welke impact ‘macro-eco-
nomische cycli’ – oftewel langdurige conjunctuurgolven – kunnen hebben op de sterf-
tekans van mensen op middelbare en oudere leeftijd. Eerdere studies over dit onder-
werp geven een tegen-intuïtieve boodschap: economische groei en afnemende werk-
loosheid worden geassocieerd met een toename van het aantal doden in de populaties 
van ontwikkelde landen.4-14 De centrale theorie achter deze bevinding is dat toene-
mende werkstress tijdens economische groei gepaard gaat met gezondheidsrisico’s, die 





onder ouderen minstens zo gevoelig is voor conjunctuurgolven als die van mensen van 
middelbare leeftijd. Dit betekent dat werkstress óf niet de juiste verklaring is, óf niet de 
enige verklaring kan zijn. Mogelijk leiden – ten tijde van hoogconjunctuur – drukkere 
wegen tot meer verkeersdoden en hogere industriële activiteit tot meer ziektegevallen 
door luchtvervuiling. Ook is het mogelijk dat een hogere werkdruk onder werkenden 
leidt tot een afname in de mantelzorg die geboden wordt aan ouderen – wellicht is man-
telzorg van groot belang voor de gezondheid van ouderen. 
In hoofdstuk 3 verschuiven we de aandacht van het economische klimaat naar 
het eigenlijke klimaat. Eerder onderzoek naar de invloed van jaargetijden op sterfte-
kans laat zien dat de sterftekans op populatieniveau toeneemt als de temperatuur af-
neemt, maar ook dat excessieve warmte kan leiden tot sterfte.15-23 Het is onbekend of 
de seizoenen invloed hebben op medische zorgkosten of institutionalisering (de op-
name in verzorgings- of verpleeghuizen). Ons onderzoek bevestigt dat er in Nederland 
meer oudere mensen sterven tijdens de koude seizoenen (herfst en winter) dan tijdens 
de warme seizoenen (lente en zomer). De medische zorgkosten laten dezelfde seizoens-
variatie zien; institutionalisering piekt alleen in de winter. Een eerste conclusie zou 
kunnen zijn dat het logisch is dat er seizoensvariatie in medische zorgkosten wordt ge-
vonden, aangezien de medische zorgkosten exponentieel stijgen voor dood (zie hoofd-
stuk 7) en de dood vaker intreedt tijdens de koude seizoenen. Echter, wij constateren 
dat de seizoensvariatie in medische zorgkosten zelfs sterker is onder ouderen die nog 
een lange(re) levensverwachting hebben. Factoren die seizoensvariatie in sterfte en 
medische zorgkosten kunnen verklaren zijn: koude temperaturen, griepepidemieën, 
gladde wegen en stoepen, maar ook veranderingen in zonlichturen, luchtdruk en lucht-
vervuiling. Hoe deze mogelijke oorzaken zich tot elkaar verhouden is onbekend. Echter, 
aangezien we vinden dat de sterftecijfers van ouderen in verzorgings- en verpleeghui-
zen – waarbinnen een constante, kunstmatige temperatuur heerst – ook seizoensvaria-
tie laten zien, kan temperatuur niet de belangrijkste reden zijn. 
In hoofdstuk 4 – het laatste hoofdstuk van deel I – richten we de aandacht op 
het landelijke zorgstelsel. We onderzoeken hier de bewering dat een sterke 1e lijnszorg 
potentie heeft om de volksgezondheid te bevorderen en de zorgkosten kan verlagen; 
vooral omdat de huisarts een rol als poortwachter vervult en daarmee kan voorkomen 
dat patiënten onnodig dure specialistische zorg ontvangen. Daarnaast kan de huisarts 
basale ingrepen of interventies verrichten tegen een lagere kostprijs. Met dit uitgangs-
punt analyseren wij of ouderen die meer zorg ontvangen van de huisarts minder kosten 
maken in de 2e of 3e lijnszorg. Uit deze studie blijkt dat zorgkosten bij de huisarts posi-
tief gecorreleerd zijn aan overige zorgkosten later in de tijd. Met andere woorden, ou-




zorgsectoren. De gedachte dat huisartsen dure specialistische zorg voorkomen is hier-
mee dus niet bekrachtigd. Echter, we kunnen maar beperkt corrigeren voor morbiditeit. 
Het is dan ook zeer waarschijnlijk dat de positieve correlatie voortkomt uit het feit dat 
zieke ouderen simpelweg meer zorgkosten maken in alle zorgsectoren. 
In deel II van dit proefschrift vernauwen we de focus en richten we ons op de 
factoren op ‘micro-niveau’ die invloed hebben op de zorguitgaven en sterftekans van 
ouderen. In hoofdstuk 5 analyseren we de effectiviteit en uitgaven van een kleinschalig 
zorgprogramma dat gericht is op het individueel toespitsen van zorgactiviteiten voor 
ouderen met multi-morbiditeit. Onze conclusie is dat voor ouderen die aan dit zoge-
naamde Herstelzorgprogramma deelnamen de uitkomsten beter waren dan voor oude-
ren die standaard zorg ontvingen, terwijl de langdurige zorguitgaven van beide groepen 
gelijk bleven. Belangrijke verbeterpunten die werden gerealiseerd in het Herstelzorg-
programma zijn: aangepast risicomanagement; een geïntegreerd en multidisciplinair 
zorgpad gericht op behoud van functie; optimalisering van communicatie en overdrach-
ten tussen verschillende zorginstellingen; en specifieke geriatrische interventies.  
In hoofdstuk 6 verschuiven we de focus van de formele zorg die een patiënt om-
ringt naar de informele zorg. We onderzoeken hier of het verliezen van de belangrijkste 
mantelzorger (de partner) impact heeft op de zorguitgaven van een ouder individu. We 
vinden dat de zorguitgaven van een oudere met ongeveer 50% toenemen in de maand 
dat hij of zij de partner verliest; deze verhoging houdt minstens 3½ jaar aan (zo ver 
reikt de studieperiode). De toename is sterker voor mannen en oudere mannen én vrou-
wen van 80 jaar of ouder. Omdat de stijging van zorguitgaven het grootst is binnen de 
langdurige zorg en omdat er geen echte piek waarneembaar is na het verliezen van een 
partner, is het waarschijnlijk dat het effect op de zorguitgaven vooral veroorzaakt 
wordt door het permanente verlies van een mantelzorger en minder door rouw. 
In hoofdstuk 7 – het laatste hoofdstuk van deel II – richten we de aandacht op 
de ‘kosten van het doodgaan’. Het is bekend dat de zorguitgaven van een individu expo-
nentieel stijgen voor zijn of haar dood.24-34 Wij onderzoeken of er veel variatie bestaat 
in de zogeheten kosten van het doodgaan en, zo ja, waar die variatie vooral door ver-
klaard kan worden. Wanneer we de medische en langdurige zorg samenvoegen, is er 
weinig variatie in de kosten van het doodgaan. Echter, binnen de sectoren zelf is wel 
variatie waarneembaar. Deze variatie wordt vooral verklaard door leeftijd: de medische 
zorguitgaven voor de dood dalen met de leeftijd terwijl de langdurige zorguitgaven voor 
de dood stijgen met de leeftijd. Zorguitgaven uit het verleden hebben ook invloed op de 
hoogte van de kosten van het doodgaan. Ouderen die 2 jaar voor hun dood relatief hoge 
zorguitgaven hebben, hebben ook meer zorguitgaven vlak voor de dood. Dit impliceert 







Zoals in de inleiding van deze samenvatting te lezen is, valt de term vergrijzing onder 
te verdelen in drie ‘dynamieken’: (1) een hogere levensverwachting; (2) een groeiend 
aandeel ouderen; (3) een hoger gemiddeld sterfterisico in de algehele populatie. Van de 
vele factoren die van invloed zijn op de zorguitgaven van ouderen, hebben we in dit 
proefschrift enkelen behandeld. De vraag die we nu behandelen is: Hoe hebben de in dit 
proefschrift behandelde factoren invloed op de drie dynamieken? 
 
Levensverwachting 
De levensverwachting is continu stijgende in ontwikkelde landen. Wat de invloed van 
deze toenemende levensverwachting is op de zorguitgaven van ouderen, is afhankelijk 
van hoe de gezonde levensverwachting zich zal ontwikkelen. Als de gezonde levensver-
wachting net zo snel stijgt als de levensverwachting, dan zal, per individu, het aantal 
levensjaren in minder goede gezondheid gelijk blijven in de toekomst. Dit betekent ver-
volgens dat er geen ‘expansie’ van zorguitgaven over de individuele levensloop zal 
plaatsvinden. Echter, als de stijging van de gezonde levensverwachting minder snel 
stijgt dan de levensverwachting, dan zullen de gemiddelde individuele zorguitgaven 
wél stijgen. 
Tussen 1985 en 2010 is in Nederland de ‘levensverwachting zonder beperkin-
gen’, als ook de ‘levensverwachting in goede zelf-ervaren gezondheid’, gelijk opgegaan 
met de levensverwachting.35 Echter, de ‘levensverwachting zonder chronische ziekte’ 
is gedaald in deze periode. Let wel, dit betekent niet dat daadwerkelijke gezondheid van 
Nederlanders is achteruitgegaan; waarschijnlijk heeft een betere diagnostisering en be-
handeling van chronische ziektes een belangrijk aandeel in de daling van deze vorm van 
levensverwachting. Echter, de prevalentie van sommige chronische ziektes – zoals dia-
betes of atriumfibrilleren – is wel toegenomen in de afgelopen decennia, wat vooral te 
verklaren is door een verslechtering van leefstijl en wellicht ook door een toename van 
het aantal ouderen, die meer ontvankelijk zijn voor dergelijke chronische ziektes. 
 
Stijgend aandeel ouderen 
De zorguitgaven stijgen in een samenleving als het aandeel ouderen toeneemt. Dat komt 
omdat, op individueel niveau, de zorguitgaven stijgen met het toenemen van de leeftijd. 
Er zijn echter verschillende ontwikkelingen gaande die de impact van een groter aan-
deel ouderen op de zorguitgaven kunnen dempen. Ten eerste zien we dat de medische 
zorguitgaven tijdens de levensloop van een individu gemiddeld genomen ongeveer con-




moment van schrijven vinden er in Nederland belangrijke beleidswijzigingen plaats – 
zoals de overheveling van bepaalde langdurige zorg van de AWBZ naar de WMO – die 
gepaard gaan met bezuinigingen. Ten tweede zien we dat ouderen na het verliezen van 
een partner een vijfvoudige toename in langdurige zorguitgaven hebben. Omdat de le-
vensverwachting van mannen sneller stijgt dan die van vrouwen, zal het aantal wedu-
wes in de toekomst afnemen. Dit gegeven zal de druk op de langdurige zorg verminde-
ren. Ten derde vinden er initiatieven plaats die de langdurige zorg in Nederland effici-
enter of effectiever kunnen maken. Hiervan is het Herstelzorgprogramma, besproken 
in dit proefschrift, één voorbeeld. 
 
Hoger gemiddeld sterfterisico 
Zoals eerder is genoemd, stijgen de individuele zorguitgaven exponentieel voor de 
dood. Het aandeel van de zorguitgaven in de laatste maanden van het leven maken hier-
door een aanzienlijk deel uit van het totale niveau aan zorguitgaven. Door de eeuwen 
heen hebben toenemende welvaart en betere zorg, voeding en hygiëne ervoor gezorgd 
dat de sterftekans is gedaald, waardoor de levensverwachting is gestegen. Aangezien 
de ‘kosten van het doodgaan’ dalen met de leeftijd, zal het toenemend aantal sterfgeval-
len tijdens de vergrijzing dus deels gecompenseerd worden door een andere compo-
nent van de vergrijzing: een toenemende levensverwachting. 
 
Toekomstig onderzoek 
Het belang en de mogelijkheden van verder onderzoek zijn groot. Het zal van grote 
waarde zijn om te kijken naar de invloeden van verschillende indicatoren van de eco-
nomische omgeving en het klimaat op verscheidene subgroepen. Daar kan dan uit ge-
deduceerd worden wat de proportionele invloed is van gewerkte uren, werkloosheid, 
ontvangen mantelzorg, verkeersvolume, luchtvervuiling, temperatuur, zonlichturen, 
enzovoorts, op de gezondheid en zorguitgaven van ouderen. Het is van belang om naar 
subgroepen te kijken, omdat we alleen dan kunnen achterhalen of sommige groepen – 
zoals alleenstaande ouderen van zeer hoge leeftijd, of werkloze mensen van middelbare 
leeftijd – vooral te lijden hebben onder bepaalde omstandigheden. Beleid zal zich dan 
moeten toespitsen op deze groepen als deze omstandigheden zich voordoen. Het is ver-
der van specifiek belang voor beleidsmakers om te achterhalen wat het aandeel is van 
de naderende dood van een oudere, of dat van zijn of haar partner, in het totale niveau 
van de individuele zorguitgaven. Vervolgens zal nagedacht moeten worden over welke 
beleidsmaatregelen zullen helpen om deze uitgaven te verminderen zonder dat dit ten 








Alhoewel de vergrijzing gepaard zal gaan met een toename in de zorguitgaven is de im-
pact van de vergrijzing beperkt in vergelijking met die van andere ontwikkelingen. Als 
we de bevindingen van dit proefschrift samenvoegen, kunnen we concluderen dat de 
impact van de vergrijzing waarschijnlijk nog ‘gedempt’ zal worden, met name door de 
toenemende levensverwachting (vooral van mannen) en de mogelijkheid om met inter-
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